| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | MPO NCOA2 NCOA3 EP400 SMC1A CALCOCO1 SRF CREBBP MEF2A STAT1 STAT3 EOMES CCNT1 CCNT2 MLH3 TLE1 TLE4 BRD4 PCBP2 HCFC1 MED12 HDAC2 | 2.47e-07 | 739 | 167 | 22 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | TRERF1 NCOA2 NCOA3 ANKRD42 SRF BCL3 CREBBP MEF2A STAT1 STAT3 STAT5A EOMES CCNT1 TLE1 TLE4 HCFC1 MED12 HDAC2 | 1.95e-06 | 582 | 167 | 18 | GO:0140297 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP6V1G2 MYO5B NSF DDX60 MYO19 SMC1A ABCC9 CLPX RFC2 MLH3 DNAH12 G3BP1 CLPB ATP2C2 TAP1 | 4.70e-06 | 441 | 167 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1G2 EP400 MYO5B NSF DDX60 MYO19 SMC1A ABCC9 CLPX RFC2 DNAH14 MLH3 DNAH12 G3BP1 CLPB ATP2C2 TAP1 | 1.62e-05 | 614 | 167 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | transcription factor binding | TRERF1 NCOA2 NCOA3 ANKRD42 SRF BCL3 CREBBP MEF2A STAT1 STAT3 STAT5A EOMES CCNT1 CCNT2 TLE1 TLE4 HCFC1 MED12 HDAC2 | 1.84e-05 | 753 | 167 | 19 | GO:0008134 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.57e-04 | 61 | 167 | 5 | GO:0030374 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TRERF1 NCOA2 NCOA3 UBQLN2 SYNE1 SGTA CALCOCO1 RICTOR BCL3 CREBBP STAT3 TAB3 CCNT1 IGF2BP2 KMT2D G3BP1 SETD5 TLE1 TLE3 TLE4 BRD4 FLRT2 PCBP2 HCFC1 MED12 | 1.58e-04 | 1356 | 167 | 25 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | TRERF1 NCOA2 NCOA3 ANKRD42 SRF CREBBP MEF2A STAT1 STAT3 EOMES MED12 HDAC2 | 2.10e-04 | 417 | 167 | 12 | GO:0061629 |
| GeneOntologyMolecularFunction | transcription coactivator activity | TRERF1 NCOA2 NCOA3 CALCOCO1 BCL3 CREBBP KMT2D BRD4 HCFC1 MED12 | 2.42e-04 | 303 | 167 | 10 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator activity | TRERF1 NCOA2 NCOA3 CALCOCO1 BCL3 CREBBP KMT2D SETD5 TLE1 TLE3 TLE4 BRD4 HCFC1 MED12 | 2.78e-04 | 562 | 167 | 14 | GO:0003712 |
| GeneOntologyMolecularFunction | chromatin DNA binding | 5.21e-04 | 167 | 167 | 7 | GO:0031490 | |
| GeneOntologyMolecularFunction | collagen binding | 5.91e-04 | 81 | 167 | 5 | GO:0005518 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 NCOA2 NCOA3 UBQLN2 SYNE1 CALCOCO1 BCL3 CREBBP STAT3 CCNT1 IGF2BP2 KMT2D G3BP1 SETD5 TLE1 TLE3 TLE4 BRD4 FLRT2 HCFC1 MED12 | 7.00e-04 | 1160 | 167 | 21 | GO:0030674 |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.02e-03 | 6 | 167 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 1.08e-03 | 54 | 167 | 4 | GO:0001223 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | TRERF1 NCOA2 IPO5 NCOA3 ITCH DDX60 CALCOCO1 TLR9 STAT3 KMT2D CLPB UBR5 PAK1 PCBP2 | 7.75e-06 | 416 | 167 | 14 | GO:0030522 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular steroid hormone receptor signaling pathway | 1.16e-05 | 18 | 167 | 4 | GO:0033145 | |
| GeneOntologyBiologicalProcess | interleukin-9-mediated signaling pathway | 1.78e-05 | 7 | 167 | 3 | GO:0038113 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-9 | 1.78e-05 | 7 | 167 | 3 | GO:0071355 | |
| GeneOntologyBiologicalProcess | response to interleukin-9 | 2.83e-05 | 8 | 167 | 3 | GO:0071104 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TRERF1 NCOA2 TET2 NCOA3 CALCOCO1 SRF GLIS3 POGZ BCL3 TLR9 PTBP1 CREBBP MEF2A STAT1 STAT3 STAT5A EOMES CCNT1 CCNT2 KMT2D BRD4 PAXIP1 PCBP2 HCFC1 MED12 HDAC2 | 5.35e-05 | 1390 | 167 | 26 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of protein localization to cilium | 8.20e-05 | 11 | 167 | 3 | GO:1903564 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular estrogen receptor signaling pathway | 1.09e-04 | 12 | 167 | 3 | GO:0033148 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 1.22e-04 | 136 | 167 | 7 | GO:0030518 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TRERF1 NCOA2 IPO5 NCOA3 EP400 SYNE1 UBQLN4 CDC20B U2AF2 RFC2 CREBBP CXXC1 SYNE4 STAT1 STAT3 STAT5A RANBP17 CCNT1 CCNT2 CPSF4 KMT2D SETD5 TLE1 TLE3 TLE4 BRD4 PAXIP1 CSTF2 SNRPG HCFC1 MED12 CHTOP HDAC2 | 6.99e-09 | 1377 | 164 | 33 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 1.03e-05 | 18 | 164 | 4 | GO:0019908 | |
| GeneOntologyCellularComponent | cyclin/CDK positive transcription elongation factor complex | 3.85e-05 | 9 | 164 | 3 | GO:0008024 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 1.28e-04 | 13 | 164 | 3 | GO:1990907 | |
| GeneOntologyCellularComponent | methyltransferase complex | 2.10e-04 | 108 | 164 | 6 | GO:0034708 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | SYNE1 TNRC6B TNRC6C IGF2BP2 G3BP1 NYNRIN PPP6R2 SNRPG GARRE1 | 2.83e-04 | 269 | 164 | 9 | GO:0036464 |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 3.07e-04 | 272 | 164 | 9 | GO:0090575 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 3.10e-04 | 75 | 164 | 5 | GO:0035097 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | SYNE1 TNRC6B TNRC6C IGF2BP2 G3BP1 NYNRIN PPP6R2 SNRPG GARRE1 | 4.53e-04 | 287 | 164 | 9 | GO:0035770 |
| GeneOntologyCellularComponent | carboxy-terminal domain protein kinase complex | 8.50e-04 | 24 | 164 | 3 | GO:0032806 | |
| GeneOntologyCellularComponent | P-body | 1.26e-03 | 102 | 164 | 5 | GO:0000932 | |
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 1.35e-03 | 61 | 164 | 4 | GO:0000307 | |
| HumanPheno | Thin upper lip vermilion | PUF60 SMC1A SPTBN1 GLIS3 TNRC6B ABCC9 POGZ CREBBP STT3A KMT2D SETD5 PACS2 MED12 | 2.36e-05 | 339 | 52 | 13 | HP:0000219 |
| HumanPheno | Thin lips | PUF60 SMC1A SPTBN1 GLIS3 TNRC6B ABCC9 POGZ CREBBP STT3A KMT2D SETD5 PACS2 MED12 | 2.36e-05 | 339 | 52 | 13 | HP:0000213 |
| HumanPheno | Compulsive behaviors | 2.48e-05 | 158 | 52 | 9 | HP:0000722 | |
| Domain | GOLGA6L | 8.90e-08 | 6 | 166 | 4 | IPR026737 | |
| Domain | Groucho_enhance | 6.81e-06 | 5 | 166 | 3 | IPR009146 | |
| Domain | TLE_N | 6.81e-06 | 5 | 166 | 3 | PF03920 | |
| Domain | Groucho/TLE_N | 6.81e-06 | 5 | 166 | 3 | IPR005617 | |
| Domain | Nuc_rcpt_coact | 1.35e-05 | 6 | 166 | 3 | IPR009110 | |
| Domain | GOLGA2L5 | 1.67e-05 | 18 | 166 | 4 | PF15070 | |
| Domain | Golgin_A | 1.67e-05 | 18 | 166 | 4 | IPR024858 | |
| Domain | STAT_TF_DNA-bd_sub | 2.35e-05 | 7 | 166 | 3 | IPR012345 | |
| Domain | STAT | 2.35e-05 | 7 | 166 | 3 | IPR001217 | |
| Domain | STAT_int | 2.35e-05 | 7 | 166 | 3 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 2.35e-05 | 7 | 166 | 3 | IPR013801 | |
| Domain | STAT_bind | 2.35e-05 | 7 | 166 | 3 | PF02864 | |
| Domain | STAT_int | 2.35e-05 | 7 | 166 | 3 | PF02865 | |
| Domain | - | 2.35e-05 | 7 | 166 | 3 | 1.10.532.10 | |
| Domain | STAT_alpha | 2.35e-05 | 7 | 166 | 3 | PF01017 | |
| Domain | - | 2.35e-05 | 7 | 166 | 3 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 2.35e-05 | 7 | 166 | 3 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 2.35e-05 | 7 | 166 | 3 | IPR015988 | |
| Domain | - | 2.35e-05 | 7 | 166 | 3 | 2.60.40.630 | |
| Domain | STAT_TF_alpha | 3.74e-05 | 8 | 166 | 3 | IPR013800 | |
| Domain | K_chnl_volt-dep_Kv1 | 3.74e-05 | 8 | 166 | 3 | IPR003972 | |
| Domain | ClpB_D2-small | 7.85e-05 | 2 | 166 | 2 | PF10431 | |
| Domain | DUF4927 | 7.85e-05 | 2 | 166 | 2 | IPR032565 | |
| Domain | ClpB_D2-small | 7.85e-05 | 2 | 166 | 2 | SM01086 | |
| Domain | DUF4927 | 7.85e-05 | 2 | 166 | 2 | PF16279 | |
| Domain | Clp_ATPase_C | 7.85e-05 | 2 | 166 | 2 | IPR019489 | |
| Domain | AAA_2 | 7.85e-05 | 2 | 166 | 2 | PF07724 | |
| Domain | HECT | 9.00e-05 | 27 | 166 | 4 | PF00632 | |
| Domain | HECTc | 9.00e-05 | 27 | 166 | 4 | SM00119 | |
| Domain | HECT_dom | 9.00e-05 | 27 | 166 | 4 | IPR000569 | |
| Domain | HECT | 9.00e-05 | 27 | 166 | 4 | PS50237 | |
| Domain | RRM | 2.21e-04 | 230 | 166 | 9 | PS50102 | |
| Domain | Ago_hook | 2.34e-04 | 3 | 166 | 2 | PF10427 | |
| Domain | DUF1518 | 2.34e-04 | 3 | 166 | 2 | PF07469 | |
| Domain | Nuc_rcpt_coact_Ncoa-typ | 2.34e-04 | 3 | 166 | 2 | IPR014920 | |
| Domain | SRC-1 | 2.34e-04 | 3 | 166 | 2 | IPR014935 | |
| Domain | Src1_rcpt_coact | 2.34e-04 | 3 | 166 | 2 | IPR008955 | |
| Domain | Nuclear_rcpt_coactivator | 2.34e-04 | 3 | 166 | 2 | IPR017426 | |
| Domain | CALCOCO1 | 2.34e-04 | 3 | 166 | 2 | PF07888 | |
| Domain | - | 2.34e-04 | 3 | 166 | 2 | 4.10.630.10 | |
| Domain | DUF1518 | 2.34e-04 | 3 | 166 | 2 | IPR010011 | |
| Domain | TNRC6_PABC-bd | 2.34e-04 | 3 | 166 | 2 | IPR032226 | |
| Domain | CALCOCO1-like | 2.34e-04 | 3 | 166 | 2 | IPR012852 | |
| Domain | Argonaute_hook_dom | 2.34e-04 | 3 | 166 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 2.34e-04 | 3 | 166 | 2 | PF16608 | |
| Domain | DUF1518 | 2.34e-04 | 3 | 166 | 2 | SM01151 | |
| Domain | SRC-1 | 2.34e-04 | 3 | 166 | 2 | PF08832 | |
| Domain | Nuc_rec_co-act | 2.34e-04 | 3 | 166 | 2 | PF08815 | |
| Domain | UBA-like | 2.61e-04 | 64 | 166 | 5 | IPR009060 | |
| Domain | AAA | 3.06e-04 | 144 | 166 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 3.06e-04 | 144 | 166 | 7 | IPR003593 | |
| Domain | - | 3.42e-04 | 244 | 166 | 9 | 3.30.70.330 | |
| Domain | ANK | ANKRD42 BCL3 ANKHD1 CLPB ANKDD1B ANKRD18A ANKRD24 TNKS2 HECTD1 | 4.20e-04 | 251 | 166 | 9 | SM00248 |
| Domain | ANK_REPEAT | ANKRD42 BCL3 ANKHD1 CLPB ANKDD1B ANKRD18A ANKRD24 TNKS2 HECTD1 | 4.45e-04 | 253 | 166 | 9 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ANKRD42 BCL3 ANKHD1 CLPB ANKDD1B ANKRD18A ANKRD24 TNKS2 HECTD1 | 4.58e-04 | 254 | 166 | 9 | IPR020683 |
| Domain | ANK_REP_REGION | ANKRD42 BCL3 ANKHD1 CLPB ANKDD1B ANKRD18A ANKRD24 TNKS2 HECTD1 | 4.58e-04 | 254 | 166 | 9 | PS50297 |
| Domain | KASH | 4.66e-04 | 4 | 166 | 2 | IPR012315 | |
| Domain | KASH | 4.66e-04 | 4 | 166 | 2 | PS51049 | |
| Domain | KASH | 4.66e-04 | 4 | 166 | 2 | SM01249 | |
| Domain | KASH | 4.66e-04 | 4 | 166 | 2 | PF10541 | |
| Domain | Nucleotide-bd_a/b_plait | 5.13e-04 | 258 | 166 | 9 | IPR012677 | |
| Domain | RRM_1 | 5.55e-04 | 208 | 166 | 8 | PF00076 | |
| Domain | Ankyrin_rpt | ANKRD42 BCL3 ANKHD1 CLPB ANKDD1B ANKRD18A ANKRD24 TNKS2 HECTD1 | 5.73e-04 | 262 | 166 | 9 | IPR002110 |
| Domain | Ank_2 | 6.90e-04 | 215 | 166 | 8 | PF12796 | |
| Domain | RRM | 7.32e-04 | 217 | 166 | 8 | SM00360 | |
| Domain | HnRNP-L/PTB | 7.72e-04 | 5 | 166 | 2 | IPR006536 | |
| Domain | RRM_dom | 9.81e-04 | 227 | 166 | 8 | IPR000504 | |
| Domain | Ank | 1.01e-03 | 228 | 166 | 8 | PF00023 | |
| Domain | Spectrin | 1.07e-03 | 23 | 166 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.07e-03 | 23 | 166 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.07e-03 | 23 | 166 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.07e-03 | 23 | 166 | 3 | IPR001589 | |
| Domain | MADS_BOX_1 | 1.15e-03 | 6 | 166 | 2 | PS00350 | |
| Domain | Ubiquilin | 1.15e-03 | 6 | 166 | 2 | IPR015496 | |
| Domain | MADS | 1.15e-03 | 6 | 166 | 2 | SM00432 | |
| Domain | SRF-TF | 1.15e-03 | 6 | 166 | 2 | PF00319 | |
| Domain | MADS_BOX_2 | 1.15e-03 | 6 | 166 | 2 | PS50066 | |
| Domain | p53-like_TF_DNA-bd | 1.26e-03 | 53 | 166 | 4 | IPR008967 | |
| Domain | ATPase_AAA_core | 1.35e-03 | 54 | 166 | 4 | IPR003959 | |
| Domain | TF_MADSbox | 1.60e-03 | 7 | 166 | 2 | IPR002100 | |
| Domain | ZnF_UBR1 | 1.60e-03 | 7 | 166 | 2 | SM00396 | |
| Domain | ZF_UBR | 1.60e-03 | 7 | 166 | 2 | PS51157 | |
| Domain | zf-UBR | 1.60e-03 | 7 | 166 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.60e-03 | 7 | 166 | 2 | IPR003126 | |
| Domain | - | 1.72e-03 | 248 | 166 | 8 | 1.25.40.20 | |
| Domain | K_chnl_volt-dep_Kv | 1.72e-03 | 27 | 166 | 3 | IPR003968 | |
| Domain | Cyclin_L/T | 2.12e-03 | 8 | 166 | 2 | IPR015429 | |
| Domain | Spectrin_repeat | 2.13e-03 | 29 | 166 | 3 | IPR002017 | |
| Domain | UBA | 2.35e-03 | 30 | 166 | 3 | SM00165 | |
| Domain | CH | 2.67e-03 | 65 | 166 | 4 | SM00033 | |
| Domain | SPEC | 2.83e-03 | 32 | 166 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.83e-03 | 32 | 166 | 3 | IPR018159 | |
| Domain | VG_K_chnl | 3.09e-03 | 33 | 166 | 3 | IPR028325 | |
| Domain | STI1 | 3.37e-03 | 10 | 166 | 2 | SM00727 | |
| Domain | STI1_HS-bd | 3.37e-03 | 10 | 166 | 2 | IPR006636 | |
| Domain | CH | 3.50e-03 | 70 | 166 | 4 | PF00307 | |
| Domain | WD40_repeat_CS | 3.50e-03 | 164 | 166 | 6 | IPR019775 | |
| Domain | - | 3.68e-03 | 71 | 166 | 4 | 1.10.418.10 | |
| Domain | Prefoldin | 3.87e-03 | 72 | 166 | 4 | IPR009053 | |
| Domain | UBA | 3.97e-03 | 36 | 166 | 3 | PF00627 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.57e-06 | 74 | 117 | 7 | M616 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 1.90e-05 | 7 | 117 | 3 | M47430 | |
| Pathway | PID_CXCR4_PATHWAY | 1.92e-05 | 100 | 117 | 7 | M124 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 3.33e-05 | 149 | 117 | 8 | M27888 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 3.79e-05 | 246 | 117 | 10 | M10189 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 4.51e-05 | 9 | 117 | 3 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 4.51e-05 | 9 | 117 | 3 | M8066 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 4.51e-05 | 9 | 117 | 3 | MM1419 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.65e-05 | 48 | 117 | 5 | M611 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 5.85e-05 | 26 | 117 | 4 | MM14793 | |
| Pathway | WP_EGFEGFR_SIGNALING | 6.04e-05 | 162 | 117 | 8 | M39334 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 6.41e-05 | 10 | 117 | 3 | M27898 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 6.41e-05 | 10 | 117 | 3 | MM15156 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 6.82e-05 | 27 | 117 | 4 | M1909 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 7.91e-05 | 28 | 117 | 4 | MM1386 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 7.91e-05 | 28 | 117 | 4 | M2529 | |
| Pathway | WP_MRNA_PROCESSING | 8.47e-05 | 126 | 117 | 7 | M39406 | |
| Pathway | BIOCARTA_BARRESTIN_PATHWAY | 8.76e-05 | 11 | 117 | 3 | MM1501 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 8.96e-05 | 220 | 117 | 9 | M27794 | |
| Pathway | WP_PDGFRBETA_PATHWAY | 9.12e-05 | 29 | 117 | 4 | M39616 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 9.12e-05 | 29 | 117 | 4 | MM1452 | |
| Pathway | BIOCARTA_IL10_PATHWAY | 1.16e-04 | 12 | 117 | 3 | MM1416 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | ATP6V1G2 ITCH SRF RICTOR TLR9 PTBP1 MEF2A STAT1 STAT3 STAT5A THBS4 PAK1 FLRT2 HDAC2 | 1.30e-04 | 532 | 117 | 14 | M27870 |
| Pathway | BIOCARTA_IL10_PATHWAY | 1.50e-04 | 13 | 117 | 3 | M6778 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 1.50e-04 | 13 | 117 | 3 | M46434 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 1.60e-04 | 62 | 117 | 5 | MM15426 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 1.72e-04 | 34 | 117 | 4 | M46422 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 1.90e-04 | 14 | 117 | 3 | M27402 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 1.90e-04 | 14 | 117 | 3 | MM1489 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 2.32e-04 | 67 | 117 | 5 | M27694 | |
| Pathway | PID_IL23_PATHWAY | 2.41e-04 | 37 | 117 | 4 | M196 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.68e-04 | 38 | 117 | 4 | MM17073 | |
| Pathway | WP_PDGF_PATHWAY | 3.27e-04 | 40 | 117 | 4 | M39555 | |
| Pathway | WP_IL9_SIGNALING | 3.48e-04 | 17 | 117 | 3 | M39644 | |
| Pathway | BIOCARTA_BARRESTIN_SRC_PATHWAY | 3.48e-04 | 17 | 117 | 3 | MM1491 | |
| Pathway | WP_MRNA_PROCESSING | PTBP3 PUF60 SMC1A U2AF2 TNRC6C PTBP1 CPSF4 G3BP1 CIZ1 CSTF2 PCBP2 SNRPG | 3.64e-04 | 451 | 117 | 12 | MM15946 |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 3.95e-04 | 42 | 117 | 4 | M48018 | |
| Pathway | PID_TCPTP_PATHWAY | 3.95e-04 | 42 | 117 | 4 | M91 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 3.95e-04 | 42 | 117 | 4 | M27272 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 4.15e-04 | 18 | 117 | 3 | M673 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 5.29e-04 | 80 | 117 | 5 | M223 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 5.73e-04 | 20 | 117 | 3 | M39002 | |
| Pathway | PID_REG_GR_PATHWAY | 5.93e-04 | 82 | 117 | 5 | M115 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 6.72e-04 | 5 | 117 | 2 | M48987 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | ATP6V1G2 ITCH SRF RICTOR TLR9 PTBP1 STAT3 STAT5A THBS4 PAK1 FLRT2 | 7.07e-04 | 418 | 117 | 11 | MM15587 |
| Pathway | PID_PDGFRB_PATHWAY | 7.13e-04 | 129 | 117 | 6 | M186 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 8.00e-04 | 296 | 117 | 9 | M27869 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 8.74e-04 | 23 | 117 | 3 | M47904 | |
| Pathway | PID_KIT_PATHWAY | 8.97e-04 | 52 | 117 | 4 | M231 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 9.52e-04 | 91 | 117 | 5 | M27101 | |
| Pathway | WP_ADIPOGENESIS_GENES | 9.77e-04 | 137 | 117 | 6 | MM15970 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 9.93e-04 | 24 | 117 | 3 | M519 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 9.93e-04 | 24 | 117 | 3 | M11520 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.00e-03 | 6 | 117 | 2 | MM15621 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.00e-03 | 6 | 117 | 2 | MM15581 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 1.12e-03 | 25 | 117 | 3 | M41829 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 1.12e-03 | 25 | 117 | 3 | MM1519 | |
| Pathway | WP_IL7_SIGNALING | 1.12e-03 | 25 | 117 | 3 | M39499 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 1.26e-03 | 26 | 117 | 3 | M39687 | |
| Pathway | PID_IL27_PATHWAY | 1.26e-03 | 26 | 117 | 3 | M36 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 1.26e-03 | 26 | 117 | 3 | MM15896 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 1.26e-03 | 26 | 117 | 3 | M27750 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | 1.26e-03 | 144 | 117 | 6 | M39691 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.35e-03 | 58 | 117 | 4 | M2049 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY | 1.40e-03 | 7 | 117 | 2 | M47431 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.40e-03 | 7 | 117 | 2 | M46421 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.63e-03 | 61 | 117 | 4 | M39540 | |
| Pathway | PID_IL12_2PATHWAY | 1.74e-03 | 62 | 117 | 4 | M54 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 1.74e-03 | 29 | 117 | 3 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 1.74e-03 | 29 | 117 | 3 | M13494 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.74e-03 | 29 | 117 | 3 | M783 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.74e-03 | 29 | 117 | 3 | MM15444 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 1.74e-03 | 29 | 117 | 3 | M779 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | ITCH TLR9 CREBBP STAT1 TAB3 STT3A G3BP1 BRD4 PCBP2 SNRPG HDAC2 | 1.85e-03 | 471 | 117 | 11 | M39009 |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.92e-03 | 30 | 117 | 3 | M207 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 1.92e-03 | 30 | 117 | 3 | M41825 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 1.95e-03 | 64 | 117 | 4 | M200 | |
| Pathway | REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION | 2.11e-03 | 31 | 117 | 3 | M661 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 2.11e-03 | 31 | 117 | 3 | M47964 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.16e-03 | 277 | 117 | 8 | MM15414 | |
| Pathway | REACTOME_ADIPOGENESIS | 2.21e-03 | 110 | 117 | 5 | M48259 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 2.32e-03 | 32 | 117 | 3 | M27900 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 2.32e-03 | 32 | 117 | 3 | M39521 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 2.32e-03 | 32 | 117 | 3 | MM14975 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 2.37e-03 | 9 | 117 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 2.37e-03 | 9 | 117 | 2 | M46436 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.47e-03 | 283 | 117 | 8 | M13087 | |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | IPO5 ITCH TLR9 CREBBP STAT1 TAB3 STT3A CCNT1 CCNT2 CPSF4 G3BP1 BRD4 PCBP2 SNRPG MED12 HDAC2 | 2.70e-03 | 888 | 117 | 16 | M48034 |
| Pathway | WP_ALSTROM_SYNDROME | 2.76e-03 | 34 | 117 | 3 | M45524 | |
| Pathway | WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS | 2.76e-03 | 34 | 117 | 3 | M48081 | |
| Pubmed | TRERF1 NCOA2 TET2 NCOA3 SP2 EP400 SMC1A ENTR1 SPTBN1 TNRC6B POGZ TNRC6C CLPX ANKHD1 RFX1 CREBBP CXXC1 MEF2A STAT1 STAT3 TAB3 STT3A STAT5A CPSF4 IGF2BP2 KMT2D DST G3BP1 TLE1 TLE3 TLE4 PAXIP1 CSTF2 GARRE1 HCFC1 RAI2 HDAC2 | 7.11e-17 | 1429 | 171 | 37 | 35140242 | |
| Pubmed | MPO TRERF1 NCOA2 TET2 NCOA3 EP400 PUF60 SMC1A POGZ PTBP1 RFC2 RFX1 CREBBP MEF2A STAT1 CCNT1 CCNT2 IGF2BP2 KMT2D G3BP1 UBR5 TLE3 BRD4 PAXIP1 PCBP2 SNRPG HCFC1 TNPO3 MED12 CHTOP HDAC2 | 3.68e-15 | 1103 | 171 | 31 | 34189442 | |
| Pubmed | TRERF1 NCOA2 TET2 NCOA3 EP400 CREBBP MEF2A CCNT1 CPSF4 KMT2D TLE1 TLE3 TLE4 BRD4 PAXIP1 HCFC1 MED12 | 2.80e-14 | 268 | 171 | 17 | 33640491 | |
| Pubmed | TRERF1 TET2 NCOA3 UBQLN4 TNRC6B POGZ RBBP8NL ANKHD1 RFX1 KMT2D DST UBR5 TLE1 TLE3 TLE4 BRD4 MED12 GOLGA3 HDAC2 | 3.21e-13 | 418 | 171 | 19 | 34709266 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA2 TET2 NCOA3 SP2 EP400 SRF POGZ CLPX CREBBP KMT2D TLE1 TLE3 BRD4 PAXIP1 CIZ1 TNKS2 SNRPG RAI2 | 1.51e-12 | 398 | 171 | 18 | 35016035 |
| Pubmed | NCOA2 EP400 PUF60 TNRC6B POGZ ANKHD1 RFX1 CREBBP STAT1 STAT3 TAB3 KMT2D BRD4 CIZ1 CSTF2 PCBP2 HCFC1 MED12 HDAC2 | 3.64e-11 | 549 | 171 | 19 | 38280479 | |
| Pubmed | CALCOCO2 IPO5 PTBP3 ITCH MYO5B NSF PUF60 SMC1A SPTBN1 TNRC6B U2AF2 PTBP1 STAT1 CCNT1 CCNT2 CPSF4 IGF2BP2 G3BP1 PAK1 FH PPP6R2 PCBP2 HECTD1 HCFC1 MED12 CHTOP HDAC2 | 1.04e-10 | 1247 | 171 | 27 | 27684187 | |
| Pubmed | CALCOCO2 UBQLN2 STBD1 SPTBN1 UBQLN4 U2AF2 RFX1 CREBBP KMT2D MTMR11 DST TENM3 CLPB UBR5 BRD4 PAXIP1 TNKS2 PCBP2 TNPO3 | 1.27e-10 | 591 | 171 | 19 | 15231748 | |
| Pubmed | TRERF1 NCOA2 NCOA3 ITCH NSF SYNE1 SPTBN1 CALCOCO1 AAK1 TNRC6B PTPN9 KCNA2 KCNA3 DST KCNA4 G3BP1 UBR5 TAGLN3 PAK1 PPP6R2 GOLGA3 LRRC15 HDAC2 | 4.47e-10 | 963 | 171 | 23 | 28671696 | |
| Pubmed | DOCK4 EP400 SYNE1 TNRC6B POGZ TNRC6C TENM3 UBR5 SETD5 TLE3 TLE4 ARHGEF9 PACS2 HERC3 CROCC | 1.98e-09 | 407 | 171 | 15 | 12693553 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MPO ITCH EP400 MYO19 SMC1A SPTBN1 AAK1 U2AF2 RICTOR POGZ PTBP1 CLPX RFC2 ANKHD1 CREBBP CXXC1 STAT1 CCNT1 IGF2BP2 DST G3BP1 UBR5 WASHC5 PYGB MED12 CHTOP | 2.93e-09 | 1353 | 171 | 26 | 29467282 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PTBP3 EP400 PUF60 SYNE1 SMC1A SPTBN1 TNRC6B U2AF2 POGZ PTBP1 CXXC1 STT3A CCNT2 CPSF4 IGF2BP2 DST BRD4 CSTF2 PZP PCBP2 SNRPG MED12 HDAC2 | 4.08e-09 | 1082 | 171 | 23 | 38697112 |
| Pubmed | NCOA2 TET2 NCOA3 TNRC6B TNRC6C CREBBP TAB3 CIZ1 GARRE1 CHTOP | 4.66e-09 | 152 | 171 | 10 | 38360978 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | IPO5 EP400 MYO5B NSF PUF60 SYNE1 SMC1A U2AF2 PTBP1 RFC2 STAT1 CPSF4 IGF2BP2 DST G3BP1 UBR5 CIZ1 CSTF2 PCBP2 TAP1 CHTOP HDAC2 | 7.57e-09 | 1024 | 171 | 22 | 24711643 |
| Pubmed | 8.35e-09 | 83 | 171 | 8 | 28794006 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NCOA2 EP400 NSF PUF60 SMC1A IFT81 POGZ ANKHD1 RFX1 CREBBP MEF2A STAT1 STAT3 KMT2D UBR5 TLE1 TLE3 TLE4 HCFC1 HDAC2 | 9.83e-09 | 857 | 171 | 20 | 25609649 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | NCOA2 NCOA3 PUF60 SMC1A U2AF2 PTBP1 STAT3 KMT2D HCFC1 MED12 HDAC2 | 1.37e-08 | 220 | 171 | 11 | 35785414 |
| Pubmed | TRERF1 NCOA2 NCOA3 ZNF487 SP2 SRF GLIS3 POGZ BCL3 RFX1 CXXC1 MEF2A STAT1 STAT3 STAT5A CPSF4 TLE3 BRD4 CIZ1 | 2.09e-08 | 808 | 171 | 19 | 20412781 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 NCOA2 TET2 NCOA3 EP400 POGZ CREBBP KMT2D TLE1 TLE3 TLE4 PAXIP1 MED12 | 2.32e-08 | 351 | 171 | 13 | 38297188 |
| Pubmed | ITCH EP400 ENTR1 AOX1 TNRC6B U2AF2 RICTOR POGZ CLPX RFC2 ANKHD1 CREBBP CCNT1 IGF2BP2 MLH3 UBR5 SETD5 BRD4 CIZ1 GARRE1 CHTOP HDAC2 | 3.48e-08 | 1116 | 171 | 22 | 31753913 | |
| Pubmed | 6.78e-08 | 43 | 171 | 6 | 33472061 | ||
| Pubmed | IPO5 PUF60 RFC2 CCNT1 CCNT2 IGF2BP2 UBR5 BRD4 PCBP2 SNRPG HCFC1 GOLGA3 LRRC15 | 7.92e-08 | 390 | 171 | 13 | 17643375 | |
| Pubmed | 8.49e-08 | 23 | 171 | 5 | 9225980 | ||
| Pubmed | NCOA2 IPO5 TET2 ITCH UBQLN2 SYNE1 SGTA SMC1A IFT81 SPTBN1 UBQLN4 POGZ CREBBP STAT1 STAT3 DST CLPB PAK1 ANKRD24 TNKS2 WDR17 HECTD1 GOLGA3 | 9.47e-08 | 1285 | 171 | 23 | 35914814 | |
| Pubmed | CALCOCO2 IPO5 COL12A1 ITCH UBQLN2 CALCOCO1 CLPX RFC2 ANKHD1 STAT1 STAT3 STT3A DST G3BP1 UBR5 GLG1 TAGLN3 CROCC PCBP2 HECTD1 TAP1 HCFC1 TNPO3 | 1.12e-07 | 1297 | 171 | 23 | 33545068 | |
| Pubmed | Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma. | 1.17e-07 | 3 | 171 | 3 | 25773877 | |
| Pubmed | 1.17e-07 | 3 | 171 | 3 | 18483262 | ||
| Pubmed | Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity. | 1.17e-07 | 3 | 171 | 3 | 30045946 | |
| Pubmed | TET2 MYO5B NSF DDX60 SMC1A SPTBN1 PTBP1 RFC2 PCBP2 MED12 HDAC2 | 1.20e-07 | 272 | 171 | 11 | 31010829 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | EP400 SMC1A POGZ RFX1 CCNT1 KMT2D G3BP1 TLE3 PAXIP1 HCFC1 MED12 HDAC2 | 1.42e-07 | 341 | 171 | 12 | 32971831 |
| Pubmed | IPO5 NCOA3 EP400 PUF60 SMC1A RFC2 CREBBP STAT1 STAT3 CCNT1 CCNT2 UBR5 TLE1 BRD4 CSTF2 PYGB HCFC1 MED12 CHTOP HDAC2 | 1.52e-07 | 1014 | 171 | 20 | 32416067 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.56e-07 | 167 | 171 | 9 | 20362541 | |
| Pubmed | IPO5 PUF60 SPTBN1 U2AF2 POGZ ANKHD1 IGF2BP2 DST G3BP1 UBR5 PYGB FH HECTD1 HCFC1 MED12 HDAC2 | 1.68e-07 | 653 | 171 | 16 | 22586326 | |
| Pubmed | EP400 SMC1A POGZ ARHGAP11A CREBBP CCNT1 MLH3 BRD4 PAXIP1 HCFC1 | 1.69e-07 | 222 | 171 | 10 | 37071664 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | IPO5 PTBP3 NSF PUF60 SMC1A SPTBN1 U2AF2 PTBP1 RFC2 RNF17 CPSF4 MYO15B BRD4 PAK1 PCBP2 | 2.19e-07 | 582 | 171 | 15 | 20467437 |
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 2.20e-07 | 85 | 171 | 7 | 16051665 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 2.95e-07 | 180 | 171 | 9 | 30110629 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TRERF1 NCOA3 EP400 SGTA SMC1A SPTBN1 AAK1 RICTOR POGZ RFX1 CCNT2 KMT2D G3BP1 TLE3 TLE4 BRD4 PACS2 | 3.15e-07 | 774 | 171 | 17 | 15302935 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | MPO NCOA2 SP2 EP400 AAK1 TNRC6B CREBBP STAT1 STAT3 CCNT1 TLE3 PAK1 HCFC1 | 3.49e-07 | 444 | 171 | 13 | 34795231 |
| Pubmed | UBQLN2 MYO5B PUF60 CALCOCO1 UBQLN4 TNRC6B U2AF2 PTBP1 ANKHD1 CXXC1 NYNRIN CSTF2 PPP6R2 PCBP2 RAI2 | 3.80e-07 | 608 | 171 | 15 | 16713569 | |
| Pubmed | 3.90e-07 | 13 | 171 | 4 | 22735158 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP2 EP400 SMC1A UBQLN4 U2AF2 POGZ PTBP1 RFC2 ARHGAP11A CXXC1 CPSF4 KMT2D DST BRD4 PAXIP1 CIZ1 CSTF2 PCBP2 SNRPG HCFC1 CHTOP HDAC2 | 4.41e-07 | 1294 | 171 | 22 | 30804502 |
| Pubmed | Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression. | 4.65e-07 | 4 | 171 | 3 | 25205818 | |
| Pubmed | 4.65e-07 | 4 | 171 | 3 | 9373245 | ||
| Pubmed | 4.65e-07 | 4 | 171 | 3 | 11290324 | ||
| Pubmed | 4.65e-07 | 4 | 171 | 3 | 8645603 | ||
| Pubmed | TFII-I enhances activation of the c-fos promoter through interactions with upstream elements. | 4.65e-07 | 4 | 171 | 3 | 9584171 | |
| Pubmed | Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. | 4.65e-07 | 4 | 171 | 3 | 15634877 | |
| Pubmed | Constitutive activation of STAT transcription factors in acute myelogenous leukemia. | 4.65e-07 | 4 | 171 | 3 | 11722592 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PTBP3 SP2 EP400 NSF PUF60 SMC1A U2AF2 PTBP1 CLPX RFC2 STAT1 STAT3 STT3A STAT5A CCNT1 IGF2BP2 WASHC5 FH PCBP2 HCFC1 TNPO3 HDAC2 | 5.99e-07 | 1318 | 171 | 22 | 30463901 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | IPO5 EP400 SMC1A SPTBN1 UBQLN4 U2AF2 POGZ RFC2 BRD4 CIZ1 CHTOP HDAC2 | 6.60e-07 | 394 | 171 | 12 | 27248496 |
| Pubmed | 6.72e-07 | 34 | 171 | 5 | 30894540 | ||
| Pubmed | IPO5 NSF DDX60 MYO19 SPTBN1 BCL3 PTBP1 CLPX RFC2 ARHGAP11A STAT3 STT3A IGF2BP2 DST G3BP1 CLPB UBR5 PCBP2 TAP1 GARRE1 HCFC1 TNPO3 CHTOP | 6.94e-07 | 1440 | 171 | 23 | 30833792 | |
| Pubmed | IPO5 NSF PUF60 SMC1A U2AF2 PTBP1 CLPX RFC2 STAT3 STT3A G3BP1 CLPB PCBP2 TNPO3 CHTOP | 9.28e-07 | 653 | 171 | 15 | 33742100 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.05e-06 | 271 | 171 | 10 | 32433965 | |
| Pubmed | IPO5 EP400 U2AF2 POGZ RFC2 CCNT1 CPSF4 TLE3 BRD4 HCFC1 HDAC2 | 1.06e-06 | 339 | 171 | 11 | 30415952 | |
| Pubmed | SP2 MYO5B SMC1A PAIP2B RICTOR MYO15B UBR3 ANKRD24 FLRT2 PPP6R2 HECTD1 KLHL18 MED12 | 1.12e-06 | 493 | 171 | 13 | 15368895 | |
| Pubmed | PTBP3 EP400 PUF60 SPTBN1 AAK1 TNRC6B U2AF2 POGZ PTBP1 CLPX RFC2 ANKHD1 STAT1 STAT3 CPSF4 IGF2BP2 G3BP1 CLPB PCBP2 HCFC1 CHTOP HDAC2 | 1.15e-06 | 1371 | 171 | 22 | 36244648 | |
| Pubmed | Stat protein transactivation domains recruit p300/CBP through widely divergent sequences. | 1.16e-06 | 5 | 171 | 3 | 10464260 | |
| Pubmed | 1.16e-06 | 5 | 171 | 3 | 8365415 | ||
| Pubmed | 1.16e-06 | 5 | 171 | 3 | 16306601 | ||
| Pubmed | 1.16e-06 | 5 | 171 | 3 | 14766010 | ||
| Pubmed | 1.16e-06 | 5 | 171 | 3 | 10428084 | ||
| Pubmed | 1.16e-06 | 5 | 171 | 3 | 1303260 | ||
| Pubmed | 1.16e-06 | 5 | 171 | 3 | 8989517 | ||
| Pubmed | 1.16e-06 | 5 | 171 | 3 | 11923478 | ||
| Pubmed | 1.16e-06 | 5 | 171 | 3 | 27417725 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 ITCH SGTA CALCOCO1 AAK1 SRF TNRC6B U2AF2 TNRC6C RBBP8NL CREBBP MEF2A DNAH14 STT3A RANBP17 SETD5 RALGPS1 TLE3 ARHGEF9 EXOC6B ANKRD24 CROCC HECTD1 | 1.23e-06 | 1489 | 171 | 23 | 28611215 |
| Pubmed | 1.28e-06 | 17 | 171 | 4 | 19183483 | ||
| Pubmed | 1.28e-06 | 17 | 171 | 4 | 16109376 | ||
| Pubmed | CALCOCO2 ITCH TLR9 ANKHD1 CREBBP STAT1 STAT3 TAB3 STT3A HCFC1 | 1.55e-06 | 283 | 171 | 10 | 21903422 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | EP400 SMC1A U2AF2 PTBP1 CREBBP CCNT1 CCNT2 CPSF4 SERPINB10 TLE3 TLE4 TNPO3 MED12 CHTOP DYRK2 | 2.00e-06 | 695 | 171 | 15 | 23602568 |
| Pubmed | 2.29e-06 | 120 | 171 | 7 | 27320910 | ||
| Pubmed | 2.31e-06 | 6 | 171 | 3 | 8573724 | ||
| Pubmed | N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. | 2.31e-06 | 6 | 171 | 3 | 14704793 | |
| Pubmed | 2.31e-06 | 6 | 171 | 3 | 17082570 | ||
| Pubmed | Stat3 dimerization regulated by reversible acetylation of a single lysine residue. | 2.31e-06 | 6 | 171 | 3 | 15653507 | |
| Pubmed | 2.31e-06 | 6 | 171 | 3 | 8892234 | ||
| Pubmed | ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases. | 2.31e-06 | 6 | 171 | 3 | 10358079 | |
| Pubmed | 2.31e-06 | 6 | 171 | 3 | 8938729 | ||
| Pubmed | Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1, causes megencephaly. | 2.31e-06 | 6 | 171 | 3 | 14686897 | |
| Pubmed | IPO5 SMC1A U2AF2 PTBP1 RFC2 STAT1 STAT3 CCNT1 IGF2BP2 G3BP1 PCBP2 HCFC1 CHTOP HDAC2 | 2.41e-06 | 615 | 171 | 14 | 31048545 | |
| Pubmed | 2.48e-06 | 78 | 171 | 6 | 28611094 | ||
| Pubmed | IPO5 STBD1 NSF SMC1A SPTBN1 AAK1 TNRC6B RICTOR STAT1 STAT3 STT3A KCNA3 DST HCFC1 MED12 | 2.50e-06 | 708 | 171 | 15 | 39231216 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | IPO5 PTBP3 PUF60 SYNE1 SMC1A SPTBN1 U2AF2 PTBP1 ANKHD1 CPSF4 IGF2BP2 G3BP1 CSTF2 PCBP2 CHTOP HDAC2 | 2.68e-06 | 807 | 171 | 16 | 22681889 |
| Pubmed | A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1. | 2.82e-06 | 45 | 171 | 5 | 25496916 | |
| Pubmed | 2.88e-06 | 80 | 171 | 6 | 35803934 | ||
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 3.85e-06 | 22 | 171 | 4 | 26886794 | |
| Pubmed | A Gro/TLE-NuRD corepressor complex facilitates Tbx20-dependent transcriptional repression. | 4.03e-06 | 7 | 171 | 3 | 24024827 | |
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 7477295 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 23797472 | ||
| Pubmed | BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells. | 4.03e-06 | 7 | 171 | 3 | 16860316 | |
| Pubmed | The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. | 4.03e-06 | 7 | 171 | 3 | 9192892 | |
| Pubmed | Expression and activation of STAT proteins during mouse retina development. | 4.03e-06 | 7 | 171 | 3 | 12634107 | |
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 25609618 | ||
| Pubmed | Physiological significance of STAT proteins: investigations through gene disruption in vivo. | 4.03e-06 | 7 | 171 | 3 | 10526573 | |
| Pubmed | Transcriptional and physiological roles for STAT proteins in leptin action. | 4.03e-06 | 7 | 171 | 3 | 30718218 | |
| Pubmed | Signaling through the JAK/STAT pathway, recent advances and future challenges. | 4.03e-06 | 7 | 171 | 3 | 12039028 | |
| Pubmed | STAT heterodimers in immunity: A mixed message or a unique signal? | 4.03e-06 | 7 | 171 | 3 | 24058793 | |
| Pubmed | Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation. | 4.03e-06 | 7 | 171 | 3 | 20670891 | |
| Interaction | HDAC1 interactions | TRERF1 IPO5 TET2 EP400 SMC1A UBQLN4 TNRC6B U2AF2 BCL3 ANKHD1 RFX1 CREBBP MEF2A STAT1 STAT3 STAT5A KMT2D KCNA3 DST G3BP1 UBR5 TLE1 TLE3 TLE4 BRD4 CROCC HECTD1 HCFC1 TNPO3 MED12 GOLGA3 HDAC2 | 7.00e-10 | 1108 | 169 | 32 | int:HDAC1 |
| Interaction | FEV interactions | NCOA2 NCOA3 SP2 EP400 SMC1A POGZ RFX1 CREBBP CXXC1 KMT2D TLE1 TLE3 TLE4 PAXIP1 | 1.84e-09 | 203 | 169 | 14 | int:FEV |
| Interaction | CEBPA interactions | MPO TRERF1 NCOA2 TET2 NCOA3 ITCH EP400 PUF60 SMC1A SPTBN1 POGZ PTBP1 RFC2 RFX1 CREBBP MEF2A STAT1 CCNT1 CCNT2 IGF2BP2 KMT2D G3BP1 UBR5 TLE3 BRD4 PAXIP1 PCBP2 SNRPG HCFC1 TNPO3 MED12 CHTOP HDAC2 | 3.14e-09 | 1245 | 169 | 33 | int:CEBPA |
| Interaction | SP7 interactions | TRERF1 NCOA2 TET2 NCOA3 EP400 SMC1A POGZ RFX1 CREBBP MEF2A CPSF4 KMT2D TLE1 TLE3 TLE4 PAXIP1 | 6.19e-09 | 304 | 169 | 16 | int:SP7 |
| Interaction | SOX2 interactions | TRERF1 NCOA2 IPO5 TET2 PTBP3 NCOA3 SP2 ITCH EP400 PCNX3 NSF PUF60 SMC1A SPTBN1 GLIS3 POGZ PTBP1 RFC2 ANKHD1 RFX1 MEF2A CCNT1 CPSF4 IGF2BP2 KMT2D G3BP1 UBR5 TLE1 CROCC2 TLE3 PAXIP1 PAK1 TNPO3 CHTOP HDAC2 | 6.51e-09 | 1422 | 169 | 35 | int:SOX2 |
| Interaction | KLF5 interactions | NCOA2 TET2 NCOA3 EP400 CREBBP KMT2D G3BP1 TLE1 TLE3 BRD4 PAXIP1 HCFC1 HDAC2 | 1.07e-08 | 195 | 169 | 13 | int:KLF5 |
| Interaction | AR interactions | TRERF1 NCOA2 TET2 NCOA3 EP400 MYO5B PUF60 SMC1A U2AF2 PTBP1 CREBBP MEF2A STAT3 CCNT1 CPSF4 KMT2D MLH3 G3BP1 UBR5 TLE1 TLE3 TLE4 BRD4 PAXIP1 PCBP2 HCFC1 MED12 HDAC2 | 1.56e-08 | 992 | 169 | 28 | int:AR |
| Interaction | EGR2 interactions | TRERF1 NCOA2 TET2 NCOA3 EP400 POGZ CREBBP KMT2D TLE1 TLE3 PAXIP1 HCFC1 | 2.27e-08 | 171 | 169 | 12 | int:EGR2 |
| Interaction | NCOA1 interactions | NCOA2 NCOA3 ITCH SRF BCL3 CREBBP STAT3 STAT5A UBR5 TLE3 HERC3 | 4.29e-08 | 146 | 169 | 11 | int:NCOA1 |
| Interaction | EP300 interactions | TRERF1 NCOA2 IPO5 NCOA3 NSF PUF60 SMC1A CALCOCO1 U2AF2 ABCC9 RICTOR BCL3 PTBP1 CLPX RFC2 CREBBP CXXC1 MEF2A STAT1 STAT3 STT3A STAT5A KMT2D G3BP1 CLPB TLE3 BRD4 PAXIP1 PCBP2 HECTD1 TNPO3 CHTOP HDAC2 | 5.48e-08 | 1401 | 169 | 33 | int:EP300 |
| Interaction | SMG7 interactions | NCOA2 NCOA3 ENTR1 TNRC6B U2AF2 TNRC6C CREBBP IGF2BP2 KMT2D G3BP1 TLE1 TLE3 TLE4 PAXIP1 GARRE1 | 8.33e-08 | 319 | 169 | 15 | int:SMG7 |
| Interaction | MYOD1 interactions | NCOA2 NCOA3 EP400 SRF CREBBP MEF2A STAT3 KMT2D TLE1 TLE3 PAXIP1 EXOC3L1 | 9.16e-08 | 194 | 169 | 12 | int:MYOD1 |
| Interaction | SOX9 interactions | 1.26e-07 | 97 | 169 | 9 | int:SOX9 | |
| Interaction | CRX interactions | TRERF1 NCOA2 TET2 NCOA3 EP400 POGZ CREBBP KMT2D MYO15B TLE1 TLE3 PAXIP1 MED12 | 2.39e-07 | 254 | 169 | 13 | int:CRX |
| Interaction | GSK3A interactions | CALCOCO2 TTC16 PUF60 ENTR1 TNRC6B U2AF2 RICTOR BCL3 TLR9 PTBP1 STAT1 DST G3BP1 UBR5 HECTD1 CHTOP GOLGA3 | 3.95e-07 | 464 | 169 | 17 | int:GSK3A |
| Interaction | PAX8 interactions | 4.03e-07 | 111 | 169 | 9 | int:PAX8 | |
| Interaction | DDB1 interactions | IPO5 TET2 PUF60 SMC1A U2AF2 RICTOR CREBBP MEF2A STAT1 CCNT1 KCNA3 UBR5 TLE1 TLE3 BRD4 PAK1 CSTF2 HECTD1 MED12 HDAC2 DYRK2 | 4.12e-07 | 697 | 169 | 21 | int:DDB1 |
| Interaction | SOX7 interactions | 4.36e-07 | 82 | 169 | 8 | int:SOX7 | |
| Interaction | TBR1 interactions | 4.69e-07 | 113 | 169 | 9 | int:TBR1 | |
| Interaction | TBXT interactions | 5.86e-07 | 116 | 169 | 9 | int:TBXT | |
| Interaction | GSC interactions | 6.89e-07 | 87 | 169 | 8 | int:GSC | |
| Interaction | CELF1 interactions | PTBP3 TNRC6B U2AF2 TNRC6C PTBP1 ANKHD1 CPSF4 IGF2BP2 G3BP1 NYNRIN BRD4 CIZ1 PCBP2 | 9.95e-07 | 288 | 169 | 13 | int:CELF1 |
| Interaction | EYA4 interactions | NCOA2 TET2 NCOA3 UBQLN2 AAK1 TNRC6B TNRC6C CREBBP TAB3 CIZ1 GARRE1 CHTOP | 1.03e-06 | 243 | 169 | 12 | int:EYA4 |
| Interaction | KDM1A interactions | TRERF1 TET2 NCOA3 EP400 FPGS ENTR1 UBQLN4 TNRC6B POGZ BCL3 TLR9 RBBP8NL ANKHD1 RFX1 STAT3 KMT2D DST UBR5 TLE3 TLE4 BRD4 MED12 GOLGA3 HDAC2 | 1.16e-06 | 941 | 169 | 24 | int:KDM1A |
| Interaction | FOXG1 interactions | 1.35e-06 | 95 | 169 | 8 | int:FOXG1 | |
| Interaction | TNKS1BP1 interactions | SPTBN1 RIBC1 TNRC6B RICTOR KCNA3 G3BP1 TLE3 TNKS2 GARRE1 HDAC2 | 1.58e-06 | 168 | 169 | 10 | int:TNKS1BP1 |
| Interaction | GCM1 interactions | 1.62e-06 | 68 | 169 | 7 | int:GCM1 | |
| Interaction | NRIP1 interactions | 1.76e-06 | 170 | 169 | 10 | int:NRIP1 | |
| Interaction | ETV4 interactions | 1.79e-06 | 69 | 169 | 7 | int:ETV4 | |
| Interaction | ZG16 interactions | 2.24e-06 | 12 | 169 | 4 | int:ZG16 | |
| Interaction | FOS interactions | NCOA2 NCOA3 EP400 SRF BCL3 ANKHD1 CREBBP STAT1 STAT3 KMT2D TLE1 PAXIP1 LRRC15 | 2.42e-06 | 312 | 169 | 13 | int:FOS |
| Interaction | CCDC8 interactions | EP400 MYO5B NSF SMC1A PCDHB11 PTBP1 RFC2 STAT1 CPSF4 IGF2BP2 DNAH12 DST G3BP1 UBR5 PCBP2 HECTD1 TAP1 CHTOP HDAC2 | 2.72e-06 | 656 | 169 | 19 | int:CCDC8 |
| Interaction | ERG interactions | NCOA2 TET2 NCOA3 PUF60 CREBBP KMT2D UBR5 TLE1 TLE3 BRD4 PAXIP1 | 2.97e-06 | 223 | 169 | 11 | int:ERG |
| Interaction | PRMT1 interactions | NCOA2 TET2 NCOA3 SPTBN1 U2AF2 PTBP1 CLPX RNF17 STAT1 TAB3 STAT5A IGF2BP2 KCNA3 G3BP1 BRD4 CIZ1 FH PCBP2 SNRPG CHTOP GOLGA3 TRIM48 HDAC2 | 3.26e-06 | 929 | 169 | 23 | int:PRMT1 |
| Interaction | PELP1 interactions | 4.56e-06 | 189 | 169 | 10 | int:PELP1 | |
| Interaction | HES6 interactions | 4.71e-06 | 52 | 169 | 6 | int:HES6 | |
| Interaction | HNF1B interactions | 4.78e-06 | 190 | 169 | 10 | int:HNF1B | |
| Interaction | HNF1A interactions | 4.89e-06 | 80 | 169 | 7 | int:HNF1A | |
| Interaction | FOXJ2 interactions | 5.32e-06 | 81 | 169 | 7 | int:FOXJ2 | |
| Interaction | BRCA1 interactions | NCOA2 IPO5 DOCK4 NCOA3 NSF SMC1A SPTBN1 TNRC6B RICTOR TNRC6C PTBP1 CLPX RFC2 CREBBP STAT1 STAT3 STAT5A DST UBR5 TLE4 BRD4 CSTF2 TNKS2 PCBP2 HCFC1 MED12 HDAC2 | 5.38e-06 | 1249 | 169 | 27 | int:BRCA1 |
| Interaction | WDR5 interactions | IPO5 TET2 PUF60 SPTBN1 U2AF2 RICTOR PTBP1 ANKHD1 CREBBP CXXC1 STT3A IGF2BP2 KMT2D G3BP1 UBR5 GLG1 TLE3 BRD4 PAXIP1 HECTD1 HCFC1 CHTOP GOLGA3 HDAC2 DYRK2 | 5.38e-06 | 1101 | 169 | 25 | int:WDR5 |
| Interaction | STAT1 interactions | DOCK4 NSF SPTBN1 U2AF2 RICTOR BCL3 CREBBP STAT1 STAT3 STAT5A KCNA3 G3BP1 BRD4 | 6.57e-06 | 342 | 169 | 13 | int:STAT1 |
| Interaction | RUVBL1 interactions | UBQLN2 EP400 U2AF2 RICTOR BCL3 ANKHD1 CREBBP KCNA3 UBR5 BRD4 PAK1 PCBP2 HECTD1 HCFC1 MED12 GOLGA3 HDAC2 | 7.20e-06 | 575 | 169 | 17 | int:RUVBL1 |
| Interaction | TPRX2 interactions | 7.30e-06 | 56 | 169 | 6 | int:TPRX2 | |
| Interaction | TBK1 interactions | CALCOCO2 NCOA2 UBQLN2 NSF TNRC6B TNRC6C TLR9 DST DTX4 PPP6R2 GARRE1 GOLGA3 HDAC2 DYRK2 | 7.82e-06 | 402 | 169 | 14 | int:TBK1 |
| Interaction | FUBP3 interactions | CALCOCO2 TNRC6B U2AF2 TNRC6C IGF2BP2 G3BP1 BRD4 PCBP2 KLHL18 GARRE1 HDAC2 DYRK2 | 8.16e-06 | 297 | 169 | 12 | int:FUBP3 |
| Interaction | KDM6A interactions | 9.35e-06 | 162 | 169 | 9 | int:KDM6A | |
| Interaction | CDC5L interactions | IPO5 TET2 PTBP3 NSF SYNE1 SMC1A SPTBN1 U2AF2 RICTOR PTBP1 RFC2 RNF17 MYO15B DST G3BP1 UBR5 BRD4 PAXIP1 PCBP2 HECTD1 SNRPG | 1.02e-05 | 855 | 169 | 21 | int:CDC5L |
| Interaction | DNAJA1 interactions | UBQLN2 ENTR1 GLIS3 U2AF2 ANKHD1 MTMR11 KCNA3 G3BP1 BRD4 PAXIP1 PAK1 HECTD1 GARRE1 MED12 GOLGA3 HDAC2 | 1.12e-05 | 533 | 169 | 16 | int:DNAJA1 |
| Interaction | NFIC interactions | 1.15e-05 | 210 | 169 | 10 | int:NFIC | |
| Interaction | PML interactions | MPO NCOA2 IPO5 TET2 SP2 EP400 NSF AAK1 SRF TNRC6B CREBBP STAT1 STAT3 CCNT1 UBR5 BRD4 PAXIP1 PAK1 PYGB TAP1 HCFC1 HDAC2 | 1.17e-05 | 933 | 169 | 22 | int:PML |
| Interaction | FOXI1 interactions | 1.24e-05 | 92 | 169 | 7 | int:FOXI1 | |
| Interaction | RXRA interactions | 1.31e-05 | 169 | 169 | 9 | int:RXRA | |
| Interaction | WWTR1 interactions | NCOA2 EP400 PUF60 TNRC6B POGZ ANKHD1 CREBBP STAT1 STAT3 TAB3 KMT2D BRD4 CSTF2 HCFC1 | 1.35e-05 | 422 | 169 | 14 | int:WWTR1 |
| Interaction | HLX interactions | 1.37e-05 | 37 | 169 | 5 | int:HLX | |
| Interaction | ZC3H7A interactions | TNRC6B TNRC6C ANKHD1 STAT3 IGF2BP2 G3BP1 NYNRIN PAK1 HECTD1 GARRE1 | 1.42e-05 | 215 | 169 | 10 | int:ZC3H7A |
| Interaction | ATF3 interactions | 1.43e-05 | 94 | 169 | 7 | int:ATF3 | |
| Interaction | GATA1 interactions | 1.44e-05 | 171 | 169 | 9 | int:GATA1 | |
| Interaction | TLX1 interactions | 1.74e-05 | 175 | 169 | 9 | int:TLX1 | |
| Interaction | RORA interactions | 1.79e-05 | 39 | 169 | 5 | int:RORA | |
| Interaction | NFYC interactions | 1.90e-05 | 177 | 169 | 9 | int:NFYC | |
| Interaction | CNOT2 interactions | 1.99e-05 | 178 | 169 | 9 | int:CNOT2 | |
| Interaction | RIPPLY2 interactions | 2.08e-05 | 20 | 169 | 4 | int:RIPPLY2 | |
| Interaction | ANKRD17 interactions | SMC1A TNRC6B RICTOR TNRC6C ANKHD1 KCNA3 G3BP1 GARRE1 HDAC2 DYRK2 | 2.18e-05 | 226 | 169 | 10 | int:ANKRD17 |
| Interaction | PIN1 interactions | NCOA3 UBQLN2 UBQLN4 U2AF2 RBBP8NL TAB3 G3BP1 TLE1 TLE3 BRD4 TAGLN3 GOLGA6L9 PCBP2 | 2.18e-05 | 383 | 169 | 13 | int:PIN1 |
| Interaction | HIF1A interactions | NCOA2 IPO5 EP400 NSF RICTOR PTBP1 RFC2 CREBBP STAT3 PCBP2 HECTD1 HCFC1 MED12 HDAC2 | 2.20e-05 | 441 | 169 | 14 | int:HIF1A |
| Interaction | NFIX interactions | 2.26e-05 | 227 | 169 | 10 | int:NFIX | |
| Interaction | TFF1 interactions | 2.29e-05 | 41 | 169 | 5 | int:TFF1 | |
| Interaction | PABPC1 interactions | IPO5 TET2 ITCH UBQLN2 PUF60 SGTA PAIP2B TNRC6B U2AF2 TNRC6C IGF2BP2 KCNA3 G3BP1 UBR5 BRD4 CSTF2 PCBP2 HDAC2 | 2.47e-05 | 699 | 169 | 18 | int:PABPC1 |
| Interaction | H2AC4 interactions | IPO5 EP400 SPTBN1 UBQLN4 U2AF2 POGZ RFC2 ANKHD1 CREBBP CXXC1 KMT2D UBR5 BRD4 CIZ1 HCFC1 | 2.47e-05 | 506 | 169 | 15 | int:H2AC4 |
| Interaction | FOXQ1 interactions | 2.55e-05 | 141 | 169 | 8 | int:FOXQ1 | |
| Interaction | NFIB interactions | 2.68e-05 | 142 | 169 | 8 | int:NFIB | |
| Interaction | CD2BP2 interactions | 2.73e-05 | 232 | 169 | 10 | int:CD2BP2 | |
| Interaction | ZNF205 interactions | 3.10e-05 | 22 | 169 | 4 | int:ZNF205 | |
| Interaction | PTBP2 interactions | 3.15e-05 | 72 | 169 | 6 | int:PTBP2 | |
| Interaction | TLX3 interactions | NCOA2 TET2 NCOA3 SMC1A POGZ KMT2D TLE1 TLE3 TLE4 PAXIP1 GOLGA6L9 | 3.62e-05 | 291 | 169 | 11 | int:TLX3 |
| Interaction | VIP interactions | 3.73e-05 | 23 | 169 | 4 | int:VIP | |
| Interaction | HCFC1 interactions | CALCOCO2 EP400 SGTA CXXC1 KMT2D KCNA3 BRD4 PAXIP1 HCFC1 TNPO3 HDAC2 | 3.85e-05 | 293 | 169 | 11 | int:HCFC1 |
| Interaction | CPSF6 interactions | IPO5 ITCH PUF60 UBQLN4 U2AF2 PTBP1 CREBBP CCNT1 CPSF4 G3BP1 BRD4 CSTF2 HCFC1 TNPO3 CHTOP | 3.86e-05 | 526 | 169 | 15 | int:CPSF6 |
| Interaction | COPB1 interactions | UBQLN2 SMC1A SPTBN1 UBQLN4 RICTOR STAT3 KCNA3 TLE3 BRD4 TAP1 HDAC2 | 3.97e-05 | 294 | 169 | 11 | int:COPB1 |
| Interaction | EN1 interactions | 3.97e-05 | 110 | 169 | 7 | int:EN1 | |
| Interaction | H2BC3 interactions | EP400 SMC1A SPTBN1 UBQLN4 U2AF2 POGZ RFC2 CREBBP KMT2D BRD4 FH CHTOP HDAC2 | 4.00e-05 | 406 | 169 | 13 | int:H2BC3 |
| Interaction | RNF2 interactions | CALCOCO2 EP400 NSF SYNE1 SMC1A U2AF2 RICTOR POGZ PTBP1 CLPX RFX1 CXXC1 KMT2D G3BP1 UBR5 GLG1 BRD4 PAXIP1 CHTOP HDAC2 | 4.03e-05 | 866 | 169 | 20 | int:RNF2 |
| Interaction | SMAD1 interactions | 4.04e-05 | 243 | 169 | 10 | int:SMAD1 | |
| Interaction | THRA interactions | 4.21e-05 | 111 | 169 | 7 | int:THRA | |
| Interaction | FOXL1 interactions | 4.24e-05 | 196 | 169 | 9 | int:FOXL1 | |
| Interaction | KCNA3 interactions | NCOA2 IPO5 STBD1 NSF PUF60 SMC1A SPTBN1 AAK1 TNRC6B RICTOR PTBP1 STAT1 STAT3 STT3A KCNA2 KCNA3 DST KCNA4 HCFC1 MED12 | 4.37e-05 | 871 | 169 | 20 | int:KCNA3 |
| Interaction | SRI interactions | 4.96e-05 | 78 | 169 | 6 | int:SRI | |
| Interaction | BICD1 interactions | 5.13e-05 | 250 | 169 | 10 | int:BICD1 | |
| Interaction | MYO18A interactions | CALCOCO2 MYO5B PUF60 MYO19 SPTBN1 RICTOR ARHGAP11A KCNA3 DST WASHC5 HECTD1 | 5.21e-05 | 303 | 169 | 11 | int:MYO18A |
| Interaction | KLF4 interactions | 6.27e-05 | 160 | 169 | 8 | int:KLF4 | |
| Interaction | CNOT3 interactions | 6.47e-05 | 207 | 169 | 9 | int:CNOT3 | |
| Interaction | GOLGA6L10 interactions | 6.99e-05 | 2 | 169 | 2 | int:GOLGA6L10 | |
| Interaction | KMT2A interactions | SGTA CREBBP CXXC1 CCNT1 KMT2D KCNA3 TLE3 BRD4 PAXIP1 HCFC1 HDAC2 | 7.18e-05 | 314 | 169 | 11 | int:KMT2A |
| Interaction | BAG2 interactions | NCOA2 PTBP3 DDX60 SGTA AAK1 RICTOR BCL3 ANKHD1 RFX1 CREBBP CXXC1 KCNA3 TLE4 BRD4 CIZ1 MED12 | 7.21e-05 | 622 | 169 | 16 | int:BAG2 |
| Interaction | MECP2 interactions | PTBP3 EP400 PUF60 SYNE1 SMC1A SPTBN1 TNRC6B U2AF2 POGZ PTBP1 RFX1 CXXC1 STT3A CCNT1 CCNT2 CPSF4 IGF2BP2 DST BRD4 CSTF2 PZP PCBP2 SNRPG MED12 HDAC2 | 7.30e-05 | 1287 | 169 | 25 | int:MECP2 |
| Interaction | FOXA3 interactions | 7.39e-05 | 52 | 169 | 5 | int:FOXA3 | |
| Interaction | PGR interactions | 7.53e-05 | 84 | 169 | 6 | int:PGR | |
| Interaction | FBXW7 interactions | NCOA3 COL12A1 EP400 PUF60 SMC1A FPGS SPTBN1 U2AF2 RICTOR POGZ PTBP1 ANKHD1 STAT1 STAT3 STAT5A IGF2BP2 KMT2D G3BP1 PAXIP1 HECTD1 MED12 CHTOP HDAC2 DYRK2 | 7.98e-05 | 1215 | 169 | 24 | int:FBXW7 |
| Interaction | PAX2 interactions | 8.05e-05 | 85 | 169 | 6 | int:PAX2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 2.24e-04 | 325 | 170 | 7 | chr9q34 | |
| Cytoband | 2p13.3 | 3.26e-04 | 36 | 170 | 3 | 2p13.3 | |
| Cytoband | 15q25.2 | 5.52e-04 | 43 | 170 | 3 | 15q25.2 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.27e-10 | 25 | 112 | 7 | 775 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD42 BCL3 ANKHD1 CLPB ANKDD1B ANKRD18A ANKRD24 TNKS2 HECTD1 | 1.97e-05 | 242 | 112 | 9 | 403 |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.48e-04 | 17 | 112 | 3 | 486 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.26e-04 | 4 | 112 | 2 | 1252 | |
| GeneFamily | Cyclins|P-TEFb complex | 2.26e-04 | 4 | 112 | 2 | 1281 | |
| GeneFamily | AAA ATPases | 3.23e-04 | 53 | 112 | 4 | 413 | |
| GeneFamily | RNA binding motif containing | 3.63e-04 | 213 | 112 | 7 | 725 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 3.76e-04 | 5 | 112 | 2 | 1086 | |
| GeneFamily | Ubiquilin family | 3.76e-04 | 5 | 112 | 2 | 783 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 7.83e-04 | 7 | 112 | 2 | 785 | |
| GeneFamily | Potassium voltage-gated channels | 1.93e-03 | 40 | 112 | 3 | 274 | |
| GeneFamily | Dyneins, axonemal | 4.87e-03 | 17 | 112 | 2 | 536 | |
| GeneFamily | Armadillo repeat containing|Importins | 5.45e-03 | 18 | 112 | 2 | 596 | |
| GeneFamily | WD repeat domain containing | 5.83e-03 | 262 | 112 | 6 | 362 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN | 7.45e-07 | 200 | 169 | 10 | M7441 | |
| Coexpression | BENPORATH_SOX2_TARGETS | SP2 COL12A1 PCNX3 SGTA UBQLN4 ARHGAP11A ANKHD1 RFX1 STAT3 EOMES G3BP1 UBR5 TLE1 TLE3 PAK1 MED12 HDAC2 | 5.81e-06 | 734 | 169 | 17 | M3835 |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_DN | 6.39e-06 | 200 | 169 | 9 | M3851 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DOCK4 TET2 ATP6V1G2 MYO5B SYNE1 SPTBN1 CALCOCO1 NDUFAF3 GLIS3 TNRC6B RICTOR ANKHD1 STAT1 CCNT2 DST RALGPS1 PAK1 PACS2 FLRT2 KLHL18 MPI | 9.15e-06 | 1102 | 169 | 21 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DOCK4 TET2 ATP6V1G2 MYO5B SYNE1 SPTBN1 CALCOCO1 NDUFAF3 GLIS3 TNRC6B RICTOR ANKHD1 STAT1 CCNT2 DST RALGPS1 PAK1 PACS2 FLRT2 KLHL18 MPI | 1.23e-05 | 1124 | 169 | 21 | MM1070 |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | 1.29e-05 | 166 | 169 | 8 | M344 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | IPO5 NCOA3 SMC1A SRF STT3A CPSF4 G3BP1 UBR5 PAK1 FLRT2 FH SNRPG DYRK2 | 1.56e-05 | 481 | 169 | 13 | M3898 |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP | 4.71e-05 | 199 | 169 | 8 | M9410 | |
| Coexpression | GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP | 4.71e-05 | 199 | 169 | 8 | M9269 | |
| Coexpression | GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN | 4.88e-05 | 200 | 169 | 8 | M9081 | |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 5.02e-05 | 101 | 169 | 6 | M15356 | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 4.35e-09 | 194 | 171 | 10 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-07 | 154 | 171 | 8 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-07 | 154 | 171 | 8 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-07 | 172 | 171 | 8 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|World / disease group, cell group and cell class | 9.06e-07 | 195 | 171 | 8 | 070c5d3bdbd4ea54a579c01c37fb99bcf823982e | |
| ToppCell | Severe-B_intermediate-14|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.31e-06 | 142 | 171 | 7 | f9cbc266fcea19bec504be4f3a28d1173c6b2e3c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-06 | 155 | 171 | 7 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-06 | 155 | 171 | 7 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.00e-06 | 168 | 171 | 7 | 94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-06 | 169 | 171 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 5.85e-06 | 178 | 171 | 7 | d8e0a696bdd6af6422d72af0413f9dbd6bc02afa | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.09e-06 | 117 | 171 | 6 | 26dec09112532f351fb7a2202bae84c365707b40 | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.09e-06 | 117 | 171 | 6 | db053c874e6739052dff1f91643e51b306236237 | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.09e-06 | 117 | 171 | 6 | 80780223502d18f0d86a29ff3cb74aa8235103c7 | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.09e-06 | 117 | 171 | 6 | 40889f4a387846abbf54469cc4faf616bfe348d0 | |
| ToppCell | Striatum-Macroglia-CSF_related|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.09e-06 | 117 | 171 | 6 | e12e37e393257db85f7f5c13454095c44f59d374 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-06 | 180 | 171 | 7 | 5c9d2d44d840cd4ec7d42d43446ba2b689e7ec43 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-06 | 180 | 171 | 7 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-06 | 180 | 171 | 7 | c60e74fbbd815a0251253a19dc520a254b2e1762 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.77e-06 | 182 | 171 | 7 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.77e-06 | 182 | 171 | 7 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.77e-06 | 182 | 171 | 7 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.08e-06 | 187 | 171 | 7 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 8.08e-06 | 187 | 171 | 7 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.27e-06 | 191 | 171 | 7 | 6c1283d51a845cff67ed5e500f7e944165297b53 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.27e-06 | 191 | 171 | 7 | e8d56e9f43943e9cc4dce83f2c234f19c2dd487d | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.27e-06 | 191 | 171 | 7 | 52e8d7dfaf1ebb6df8bf3a1f4546af59faa67657 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.27e-06 | 191 | 171 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.27e-06 | 191 | 171 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.27e-06 | 191 | 171 | 7 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.27e-06 | 191 | 171 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-05 | 194 | 171 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 1.06e-05 | 195 | 171 | 7 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-05 | 195 | 171 | 7 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.06e-05 | 195 | 171 | 7 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | TCGA-Endometrium|World / Sample_Type by Project: Shred V9 | 1.12e-05 | 130 | 171 | 6 | 101d9bf4bdf10c4f5e852067297a3bc6e735d794 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 199 | 171 | 7 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 1.21e-05 | 199 | 171 | 7 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 1.21e-05 | 199 | 171 | 7 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 199 | 171 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 1.25e-05 | 200 | 171 | 7 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 200 | 171 | 7 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 200 | 171 | 7 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.25e-05 | 200 | 171 | 7 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 200 | 171 | 7 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 200 | 171 | 7 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.25e-05 | 200 | 171 | 7 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 200 | 171 | 7 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 152 | 171 | 6 | b61d2f6ee819c8dd4b4b601a8bc8388b1983de58 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-05 | 154 | 171 | 6 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-05 | 154 | 171 | 6 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.48e-05 | 159 | 171 | 6 | 5543f5aec6352a7c5923e55daf3ed40ff5cc0f0c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 162 | 171 | 6 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 4.00e-05 | 163 | 171 | 6 | 7d7f18e5c99be125e95bc180823430291b770d05 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-05 | 163 | 171 | 6 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-05 | 163 | 171 | 6 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 4.58e-05 | 167 | 171 | 6 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.74e-05 | 168 | 171 | 6 | 53a982869dbf14f6a948589be9f2f3df3b9a7e97 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Deuterosomal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.23e-05 | 171 | 171 | 6 | 52aec5f6677fe2f7a36fb5b18117a4cffaeff58f | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 5.40e-05 | 172 | 171 | 6 | 6b8a8d3b97c10b9d092307eed3cacbd2745df185 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.58e-05 | 173 | 171 | 6 | b6bb2a136a40f0946bbcde8d5972d3f059d080c7 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.58e-05 | 173 | 171 | 6 | 5d3c917e4d0de3158550a8ab2006ddfa87159ffa | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.76e-05 | 174 | 171 | 6 | 43c0e758fa8683708475aec846929ac70d41d7f5 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 5.76e-05 | 174 | 171 | 6 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 6.13e-05 | 176 | 171 | 6 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.13e-05 | 176 | 171 | 6 | d6d7e4e937d49a5c0d16322c8dd3bf9e97eb8732 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.13e-05 | 176 | 171 | 6 | c03d80df2550c0d2b0452326480d6bf21d20fdd2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 177 | 171 | 6 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 6.33e-05 | 177 | 171 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.33e-05 | 177 | 171 | 6 | 345cebc19f93970a9a46be139208b300081f5493 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.33e-05 | 177 | 171 | 6 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.33e-05 | 177 | 171 | 6 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.33e-05 | 177 | 171 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 178 | 171 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 178 | 171 | 6 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.53e-05 | 178 | 171 | 6 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 178 | 171 | 6 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.73e-05 | 179 | 171 | 6 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 6.73e-05 | 179 | 171 | 6 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.38e-05 | 182 | 171 | 6 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.38e-05 | 182 | 171 | 6 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 8.08e-05 | 185 | 171 | 6 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | 18-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 8.32e-05 | 186 | 171 | 6 | 58ab1360a1730655a5939295ba05997ac4a2d14e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.57e-05 | 187 | 171 | 6 | 6e5c38425b6b1d4774f8dcea7e146f1eab785c3e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.57e-05 | 187 | 171 | 6 | 269145d71576cbe8fa217090c8aac82d915dbc04 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.57e-05 | 187 | 171 | 6 | 43ef900b76f3c38bd8ce9858201124130c743d56 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.57e-05 | 187 | 171 | 6 | 7a50aded3243bef2075fb3ec550939ce0694919a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.57e-05 | 187 | 171 | 6 | 629b3e05840eb10e598b8dfaabd92ebe02f9995a | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 8.82e-05 | 188 | 171 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 9.09e-05 | 189 | 171 | 6 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.35e-05 | 190 | 171 | 6 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.35e-05 | 190 | 171 | 6 | 896b5825edb30fe62cbbed6078570c1f8057a99e | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.63e-05 | 191 | 171 | 6 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.63e-05 | 191 | 171 | 6 | acd844b477a069b2dcf07b2998e1b5c87dc0eb94 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.63e-05 | 191 | 171 | 6 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 9.63e-05 | 191 | 171 | 6 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 9.63e-05 | 191 | 171 | 6 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.63e-05 | 191 | 171 | 6 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-05 | 191 | 171 | 6 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-05 | 191 | 171 | 6 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 1.89e-06 | 193 | 169 | 10 | 6964_DN | |
| Drug | Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; PC3; HG-U133A | 2.07e-06 | 195 | 169 | 10 | 1949_DN | |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; PC3; HT_HG-U133A | SPTBN1 AAK1 BCL3 CCNT1 PIERCE1 TAGLN3 ARHGEF9 TNKS2 PCBP2 MPI | 2.38e-06 | 198 | 169 | 10 | 6314_DN |
| Drug | minocycline; Up 200; 10.5uM; MCF7; HT_HG-U133A_EA | 2.49e-06 | 199 | 169 | 10 | 1135_UP | |
| Drug | Cyclizine hydrochloride [303-25-3]; Up 200; 13.2uM; PC3; HT_HG-U133A | 2.49e-06 | 199 | 169 | 10 | 5100_UP | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 8.33e-06 | 180 | 169 | 9 | 1171_UP | |
| Drug | zoniporide | 1.38e-05 | 7 | 169 | 3 | ctd:C424422 | |
| Drug | Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.46e-05 | 193 | 169 | 9 | 2166_DN | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; HL60; HG-U133A | 1.52e-05 | 194 | 169 | 9 | 1759_UP | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.58e-05 | 195 | 169 | 9 | 6234_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.58e-05 | 195 | 169 | 9 | 1836_DN | |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.65e-05 | 196 | 169 | 9 | 5833_DN | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A | 1.65e-05 | 196 | 169 | 9 | 7057_DN | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.65e-05 | 196 | 169 | 9 | 7124_DN | |
| Drug | DO 897/99; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.72e-05 | 197 | 169 | 9 | 7462_DN | |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; PC3; HG-U133A | 1.72e-05 | 197 | 169 | 9 | 1899_DN | |
| Drug | Thalidomide [50-35-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.72e-05 | 197 | 169 | 9 | 2095_DN | |
| Drug | nocodazole; Down 200; 1uM; MCF7; HG-U133A | 1.79e-05 | 198 | 169 | 9 | 621_DN | |
| Drug | Guanethidine sulfate [60-02-6]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.79e-05 | 198 | 169 | 9 | 5731_DN | |
| Drug | minocycline; Down 200; 10.5uM; MCF7; HT_HG-U133A_EA | 1.79e-05 | 198 | 169 | 9 | 1135_DN | |
| Drug | Ethamivan [304-84-7]; Down 200; 18uM; MCF7; HT_HG-U133A | 1.86e-05 | 199 | 169 | 9 | 7021_DN | |
| Drug | Doxepin hydrochloride [1229-29-4]; Down 200; 12.6uM; PC3; HT_HG-U133A | 1.86e-05 | 199 | 169 | 9 | 6337_DN | |
| Drug | dichloromethotrexate | 2.19e-05 | 8 | 169 | 3 | CID000010713 | |
| Drug | geldanamycin | NCOA2 TET2 PTBP3 COL12A1 SMC1A SPTBN1 DST G3BP1 TLE4 TNKS2 PCBP2 HECTD1 | 2.25e-05 | 371 | 169 | 12 | ctd:C001277 |
| Drug | digitoxigenine | 3.78e-05 | 51 | 169 | 5 | CID000008932 | |
| Drug | 2,4-dihydroxy-N-(4-hydroxyphenyl)benzamide | 4.64e-05 | 10 | 169 | 3 | ctd:C585912 | |
| Drug | potassium hydride | 4.88e-05 | 128 | 169 | 7 | CID000082127 | |
| Drug | 1-Formyl-4-methylpiperazine | 5.22e-05 | 28 | 169 | 4 | CID003269221 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 5.27e-05 | 176 | 169 | 8 | 7499_DN | |
| Drug | NSC-289566 | 5.48e-05 | 2 | 169 | 2 | CID000324378 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 9.70e-05 | 192 | 169 | 8 | 1971_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 1.04e-04 | 194 | 169 | 8 | 4736_DN | |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.04e-04 | 194 | 169 | 8 | 4176_DN | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; HL60; HT_HG-U133A | 1.08e-04 | 195 | 169 | 8 | 2956_DN | |
| Drug | AC1L9FY1 | 1.08e-04 | 101 | 169 | 6 | CID000444218 | |
| Drug | Nor-MDP | 1.09e-04 | 13 | 169 | 3 | CID000124876 | |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.12e-04 | 196 | 169 | 8 | 6315_DN | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A | 1.12e-04 | 196 | 169 | 8 | 2086_UP | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.12e-04 | 196 | 169 | 8 | 3353_DN | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A | 1.12e-04 | 196 | 169 | 8 | 3767_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; PC3; HG-U133A | 1.16e-04 | 197 | 169 | 8 | 1938_DN | |
| Drug | 1-phenylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.16e-04 | 197 | 169 | 8 | 22_DN | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | 1.16e-04 | 197 | 169 | 8 | 1828_DN | |
| Drug | Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.16e-04 | 197 | 169 | 8 | 5343_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.16e-04 | 197 | 169 | 8 | 6455_DN | |
| Drug | Nimodipine [66085-59-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.16e-04 | 197 | 169 | 8 | 6320_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.16e-04 | 197 | 169 | 8 | 4998_DN | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.20e-04 | 198 | 169 | 8 | 6497_DN | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.20e-04 | 198 | 169 | 8 | 3681_DN | |
| Drug | haloperidol; Down 200; 10uM; PC3; HT_HG-U133A | 1.20e-04 | 198 | 169 | 8 | 1244_DN | |
| Drug | Aminohippuric acid [61-78-9]; Down 200; 20.6uM; PC3; HT_HG-U133A | 1.20e-04 | 198 | 169 | 8 | 6294_DN | |
| Drug | 0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A | 1.20e-04 | 198 | 169 | 8 | 6426_DN | |
| Drug | Tomatidine [77-59-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.20e-04 | 198 | 169 | 8 | 2746_DN | |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.20e-04 | 198 | 169 | 8 | 7016_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A | 1.20e-04 | 198 | 169 | 8 | 2700_DN | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; HL60; HG-U133A | 1.24e-04 | 199 | 169 | 8 | 1364_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; PC3; HT_HG-U133A | 1.24e-04 | 199 | 169 | 8 | 7384_UP | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.24e-04 | 199 | 169 | 8 | 7326_DN | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; HL60; HT_HG-U133A | 1.29e-04 | 200 | 169 | 8 | 1278_DN | |
| Drug | KC8851 | 1.64e-04 | 3 | 169 | 2 | CID000065956 | |
| Drug | AC1Q1NVI | 1.64e-04 | 3 | 169 | 2 | CID006439529 | |
| Drug | Oncostatin M | 1.64e-04 | 3 | 169 | 2 | ctd:D053683 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 4.73e-07 | 12 | 167 | 4 | DOID:3319 (is_marker_for) | |
| Disease | Cornelia De Lange Syndrome | 9.77e-06 | 8 | 167 | 3 | C0270972 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.34e-05 | 26 | 167 | 4 | DOID:234 (is_implicated_in) | |
| Disease | stomach cancer (is_marker_for) | 1.72e-05 | 142 | 167 | 7 | DOID:10534 (is_marker_for) | |
| Disease | Prostatic Neoplasms | MPO NCOA2 TET2 NCOA3 AOX1 CREBBP STAT3 KMT2D SERPINB10 BRD4 CIZ1 TAP1 MED12 | 5.25e-05 | 616 | 167 | 13 | C0033578 |
| Disease | Malignant neoplasm of prostate | MPO NCOA2 TET2 NCOA3 AOX1 CREBBP STAT3 KMT2D SERPINB10 BRD4 CIZ1 TAP1 MED12 | 5.25e-05 | 616 | 167 | 13 | C0376358 |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 6.43e-05 | 74 | 167 | 5 | DOID:3748 (is_marker_for) | |
| Disease | amyotrophic lateral sclerosis type 15 (implicated_via_orthology) | 9.52e-05 | 3 | 167 | 2 | DOID:0060206 (implicated_via_orthology) | |
| Disease | Bladder Neoplasm | 1.51e-04 | 140 | 167 | 6 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.57e-04 | 141 | 167 | 6 | C0005684 | |
| Disease | Neurodevelopmental Disorders | 1.90e-04 | 93 | 167 | 5 | C1535926 | |
| Disease | prostate cancer (is_marker_for) | 2.71e-04 | 156 | 167 | 6 | DOID:10283 (is_marker_for) | |
| Disease | Malignant Cystosarcoma Phyllodes | 3.15e-04 | 5 | 167 | 2 | C0600066 | |
| Disease | angiomyolipoma (is_marker_for) | 3.15e-04 | 5 | 167 | 2 | DOID:3314 (is_marker_for) | |
| Disease | Congenital muscular hypertrophy-cerebral syndrome | 3.15e-04 | 5 | 167 | 2 | C1802395 | |
| Disease | Cornelia de Lange Syndrome 3 | 3.15e-04 | 5 | 167 | 2 | C1853099 | |
| Disease | Cornelia de Lange Syndrome 1 | 3.15e-04 | 5 | 167 | 2 | C4551851 | |
| Disease | Phyllodes Tumor | 3.15e-04 | 5 | 167 | 2 | C0010701 | |
| Disease | De Lange syndrome | 4.71e-04 | 6 | 167 | 2 | cv:C0270972 | |
| Disease | Sezary Syndrome | 4.71e-04 | 27 | 167 | 3 | C0036920 | |
| Disease | amino acid measurement | IPO5 PTBP3 ITGA11 SYNE1 TGM6 CCNT2 DNAH12 PAK1 AIFM3 FLRT2 TNKS2 TRIM48 | 5.08e-04 | 678 | 167 | 12 | EFO_0005134 |
| Disease | chronic obstructive pulmonary disease (biomarker_via_orthology) | 5.26e-04 | 28 | 167 | 3 | DOID:3083 (biomarker_via_orthology) | |
| Disease | breast cancer (is_marker_for) | 6.69e-04 | 185 | 167 | 6 | DOID:1612 (is_marker_for) | |
| Disease | Mammary Carcinoma, Human | 8.57e-04 | 525 | 167 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 8.57e-04 | 525 | 167 | 10 | C1257931 | |
| Disease | panic disorder | 8.57e-04 | 33 | 167 | 3 | EFO_0004262 | |
| Disease | Mammary Neoplasms | 8.82e-04 | 527 | 167 | 10 | C1458155 | |
| Disease | nephroblastoma (is_marker_for) | 9.37e-04 | 34 | 167 | 3 | DOID:2154 (is_marker_for) | |
| Disease | Breast Carcinoma | 1.03e-03 | 538 | 167 | 10 | C0678222 | |
| Disease | Malignant neoplasm of breast | TRERF1 NCOA2 NCOA3 PNLIPRP1 SYNE1 ARHGAP11A STAT1 STAT3 STAT5A EOMES KMT2D TLE3 PAK1 EXOC3L1 MED12 | 1.21e-03 | 1074 | 167 | 15 | C0006142 |
| Disease | Malignant neoplasm of liver | 1.31e-03 | 142 | 167 | 5 | C0345904 | |
| Disease | Liver neoplasms | 1.31e-03 | 142 | 167 | 5 | C0023903 | |
| Disease | C-reactive protein measurement | TRERF1 DOCK4 ARPP21 ENTR1 NTSR1 RICTOR BCL3 PTBP1 STAT3 RANBP17 SETD5 NYNRIN TLE4 EXOC6B PYGB TNPO3 | 1.41e-03 | 1206 | 167 | 16 | EFO_0004458 |
| Disease | Arthritis, Collagen-Induced | 1.51e-03 | 40 | 167 | 3 | C0971858 | |
| Disease | Arthritis, Experimental | 1.51e-03 | 40 | 167 | 3 | C0993582 | |
| Disease | Arthritis, Adjuvant-Induced | 1.51e-03 | 40 | 167 | 3 | C0003865 | |
| Disease | Seizures | 1.56e-03 | 218 | 167 | 6 | C0036572 | |
| Disease | red blood cell density measurement | TET2 EP400 SPTBN1 TNRC6B RICTOR RBBP8NL DST KCNA4 UBR5 TLE3 BRD4 CROCC TRIM48 | 1.56e-03 | 880 | 167 | 13 | EFO_0007978 |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.69e-03 | 11 | 167 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 1.74e-03 | 42 | 167 | 3 | DOID:8991 (is_marker_for) | |
| Disease | Uterine leiomyoma | 1.80e-03 | 91 | 167 | 4 | HP_0000131 | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 2.02e-03 | 12 | 167 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.12e-03 | 45 | 167 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Acute Promyelocytic Leukemia | 2.26e-03 | 46 | 167 | 3 | C0023487 | |
| Disease | thyroid stimulating hormone measurement | 2.52e-03 | 323 | 167 | 7 | EFO_0004748 | |
| Disease | Adenoid Cystic Carcinoma | 2.55e-03 | 100 | 167 | 4 | C0010606 | |
| Disease | myeloid white cell count | MPO TET2 IFT81 SPTBN1 UBQLN4 GLIS3 SPATA32 EOMES CCNT1 GLG1 TLE3 PLEK TNKS2 | 2.70e-03 | 937 | 167 | 13 | EFO_0007988 |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 2.87e-03 | 50 | 167 | 3 | C1862939 | |
| Disease | Rheumatoid Arthritis | 3.18e-03 | 174 | 167 | 5 | C0003873 | |
| Disease | Lymphoma, Follicular, Grade 2 | 3.19e-03 | 15 | 167 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 3.19e-03 | 15 | 167 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 3.19e-03 | 15 | 167 | 2 | C1956130 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 3.19e-03 | 15 | 167 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Lymphoma, Large-Cell, Follicular | 3.19e-03 | 15 | 167 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 3.19e-03 | 15 | 167 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 3.19e-03 | 15 | 167 | 2 | C0079758 | |
| Disease | T-Cell Lymphoma | 3.63e-03 | 16 | 167 | 2 | C0079772 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 3.71e-03 | 111 | 167 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | Intellectual Disability | 4.08e-03 | 447 | 167 | 8 | C3714756 | |
| Disease | cortical surface area measurement | NCOA2 TET2 ITGA11 ITCH PCNX3 NSF SPTBN1 GLIS3 TNRC6B STAT1 MTMR11 RALGPS1 TLE4 EXOC6B PCBP2 CTSO | 4.15e-03 | 1345 | 167 | 16 | EFO_0010736 |
| Disease | X-12063 measurement | 4.22e-03 | 186 | 167 | 5 | EFO_0021283 | |
| Disease | cortical thickness | NCOA2 COL12A1 NSF SPTBN1 PCDHB11 GLIS3 TNRC6B ABCC9 STAT1 G3BP1 SETD5 RALGPS1 PYGB KLHL18 | 4.48e-03 | 1113 | 167 | 14 | EFO_0004840 |
| Disease | colon cancer (is_marker_for) | 4.59e-03 | 59 | 167 | 3 | DOID:219 (is_marker_for) | |
| Disease | Child Behaviour Checklist assessment | 4.59e-03 | 18 | 167 | 2 | EFO_0005661 | |
| Disease | lupus nephritis (is_implicated_in) | 4.59e-03 | 18 | 167 | 2 | DOID:0080162 (is_implicated_in) | |
| Disease | Myeloid Leukemia | 4.59e-03 | 18 | 167 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 4.59e-03 | 18 | 167 | 2 | C0023466 | |
| Disease | HbA1c measurement | TET2 NSF GLIS3 TNRC6C PTBP1 EOMES IGF2BP2 KCNA4 PCOLCE2 PLEK | 5.26e-03 | 675 | 167 | 10 | EFO_0004541 |
| Disease | Squamous cell carcinoma | 5.49e-03 | 124 | 167 | 4 | C0007137 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 5.66e-03 | 20 | 167 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | Lymphoma, Follicular | 5.66e-03 | 20 | 167 | 2 | C0024301 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VQGMQSSQQRNRERV | 81 | O95670 | |
| SQARGLLQGMSQALQ | 101 | Q86VI1 | |
| NNKGANNNNTQMIVL | 376 | O95936 | |
| ALTQATAAGQQVQMI | 3076 | Q96L91 | |
| ANLIQEMGQRLNVSQ | 41 | O60583 | |
| AMAILQDLRQQIQAG | 371 | A0A096LP49 | |
| QQNIRISSQDMFGQT | 221 | Q8IVF6 | |
| NLQNRIRDQMQTISN | 511 | Q9NQ75 | |
| NALGASMQQQVNQQI | 251 | O76031 | |
| GGQVVNLMNQRLQTG | 131 | Q2M2I8 | |
| NLMNQRLQTGFTENE | 136 | Q2M2I8 | |
| QAQSSQPQSMLDQQR | 1311 | O60885 | |
| AQGRVAAQNMLAQEA | 491 | Q96NN9 | |
| SLINQASQGQAQVMN | 196 | Q92793 | |
| GQINNLVAIETNQLM | 411 | O60706 | |
| AANLLQDMGQRLNVS | 41 | O60563 | |
| QDMGQRLNVSQLTIN | 46 | O60563 | |
| ILSQILQMQRLQAQG | 1131 | Q8TF21 | |
| VQNSPQEARNMLLQN | 151 | P33240 | |
| DFNTMGQINRQTQRQ | 136 | Q9Y2E6 | |
| NNGITLQMARVSQQG | 231 | Q5JU67 | |
| LDISNNQLRMLTQGV | 281 | O43155 | |
| QQPLRSAMVGQSQQQ | 506 | Q9UBL0 | |
| VANNAVIRKNAVMGQ | 441 | O75185 | |
| AAALAVMRNVTQQIN | 271 | O43307 | |
| ALNNNTTQGQAMVVE | 121 | P55064 | |
| VQALIMNGANLTAQD | 81 | Q8N9B4 | |
| AQRQENALAIVNSGM | 431 | Q06278 | |
| SGNQGQQMIQLLLAA | 496 | Q149M9 | |
| ANNRLENGMAQLITT | 21 | Q9Y5P3 | |
| ATQAGQRLLHFMQQN | 961 | Q9H2T7 | |
| VLGDILGSAMQNIQN | 956 | P20742 | |
| QAMGQLQQQLNGLSV | 81 | Q9ULR5 | |
| NEQRSNQMNNILRII | 226 | Q5JS13 | |
| NTQQNMQLGRLCDIL | 471 | Q86VS3 | |
| VVRNQQSLAVSNMGA | 486 | P43378 | |
| ITNNADIQQMNRPSN | 341 | Q6ZW49 | |
| QAVLQAAQQAVMGTG | 1636 | P51610 | |
| QQLAAGGMFRNNTLN | 86 | Q5BN46 | |
| AQQGQQAMSLAILRV | 281 | P16389 | |
| NLNEVVSALTAQQMR | 181 | Q7Z3D4 | |
| NKLTVMVRQAAEQGQ | 261 | P30989 | |
| QVTMAIVQARAQSNQ | 156 | A4FU01 | |
| QLQLNRAQQMTGAAV | 201 | Q96H55 | |
| LRSELNVVLQNMNQV | 1146 | Q03001 | |
| ELQMQVAVNGANLQN | 671 | Q15034 | |
| NGNVEQARMVLQNLS | 1086 | Q8IY21 | |
| GSIQNAKQALRNMIN | 1756 | Q9H6A9 | |
| AANNVRVVGAQVAQM | 136 | P54315 | |
| GMAANILKNNRIQNQ | 536 | Q9UHC1 | |
| MSNQLGLLAVNQRFQ | 356 | P05164 | |
| KNIRQLAEMQNAAGV | 621 | Q9Y4C0 | |
| TSANQVQNIIMARLD | 1926 | Q6ZR08 | |
| QGNGQQAMSLAILRV | 351 | P22001 | |
| LRQQLQQSQGMLGQS | 1911 | Q93074 | |
| VEQLNNILVIGMTNR | 361 | P46459 | |
| VGRQLQAEVENNQML | 176 | A6NEY3 | |
| VGRQLQAEVENNQML | 176 | A6NEF3 | |
| VGRQLQAEVENNQML | 176 | A6NEM1 | |
| VGRQLQAEVENNQML | 176 | A6NI86 | |
| VGRQLQAEVENNQML | 176 | H0YKK7 | |
| IGETAMKQAQQQRNL | 216 | Q9Y2D4 | |
| NDMLAVNQQANLIPG | 351 | Q9Y6M1 | |
| NNRSLTIHQAMRGQQ | 461 | Q9UKX5 | |
| NLAIQQAGKNMSARL | 346 | Q9UKZ9 | |
| RDRMTPSGFQQQQQQ | 411 | Q02078 | |
| TARQQQNMLRVLIDG | 841 | Q86VP3 | |
| LLQTMEDQGNQRVQA | 446 | O00410 | |
| LRQQMTALQSQLQQV | 536 | Q08378 | |
| LVKRISQQAAAGNNM | 216 | P34949 | |
| ILQNVARLQGVSNMR | 41 | Q6R327 | |
| NEIRQMSGAQIKIAN | 311 | Q15366 | |
| MENQGTRTQQIRQVL | 1 | Q9Y5F2 | |
| QQQALILAQQMTAQA | 881 | Q96JP2 | |
| ATGQEVAIKQMNLQQ | 291 | Q13153 | |
| QLQRSQLQGAMQQFN | 401 | Q96J02 | |
| QNLQRIFILTNEMNG | 96 | Q8NC74 | |
| LGMNCQQALQTLIQE | 476 | Q92896 | |
| QQRSASLAQVNAMLR | 226 | Q5TZA2 | |
| QQQQQQIKRSARMCG | 156 | Q9P0U4 | |
| RVANIARTNATNNMN | 1551 | Q9ULT8 | |
| QRVQNQLKSMRQAAA | 241 | Q8WYA0 | |
| LAIDQQNVQSLLMGA | 101 | O94889 | |
| LISQCQTRQMQNINP | 1486 | Q8N1I0 | |
| VCEQLISGQMNRFNQ | 2911 | Q99715 | |
| DQEAQMGTLQQALQG | 741 | H7BZ55 | |
| DGALRQNQQLQAQMT | 1551 | H7BZ55 | |
| VALQNLRVVMNSAQA | 386 | Q96C92 | |
| GTQTNMNVNEVISNR | 146 | P07954 | |
| VVQVMGLLSNNNQAL | 91 | Q13283 | |
| NQISPSLQRAMNAAN | 21 | Q8NEA6 | |
| VAGVSQAMQQKRQAQ | 851 | O15063 | |
| QLQQILMTVNQGNRS | 156 | A2RUB6 | |
| MGIRVDQLQAQLSTQ | 226 | Q13137 | |
| LCTVIMQNNANGNLI | 2821 | Q0VDD8 | |
| TQNVVQQANGKMQLC | 171 | Q86Y33 | |
| QDAVRMLNTLQTNAG | 46 | Q05932 | |
| LMVAAINRNNSVVQV | 171 | Q9H078 | |
| VIGVMQSQNSSAGNR | 221 | O95639 | |
| ILRQQIENMTQLVGQ | 566 | Q5M9N0 | |
| GAVKLNRQQTDMAVN | 121 | Q92769 | |
| MVQLLLQHGANVNAQ | 291 | P20749 | |
| VAQMKDTLGQAQQRV | 321 | Q9P1Z2 | |
| LRTNLAQMTDANGNI | 576 | Q92630 | |
| AQMTDANGNIQQRTV | 581 | Q92630 | |
| NMGHLTRIANAVVQN | 476 | O75170 | |
| ANQLVRVGSNNQDGM | 281 | Q9P2P1 | |
| NNNMGISSGINNRVL | 976 | Q6P4F7 | |
| QRTQRNMNSGISQVF | 11 | Q8IWZ4 | |
| IQQQMLQAQRNVSGS | 1166 | Q9HCJ0 | |
| LQAQRNVSGSMRQQE | 1171 | Q9HCJ0 | |
| NVSGSMRQQEQQVAR | 1176 | Q9HCJ0 | |
| RFNQAQSGNIQSTVM | 121 | P42224 | |
| MATATIALQVNGQQG | 1 | Q9UHX1 | |
| ASLIQAGQQFAQQMQ | 271 | O43765 | |
| LEQQQSALGMLRQQT | 5261 | Q8NF91 | |
| ALAQSGMVQLQALQV | 131 | Q8N205 | |
| QLRQGQNVIGLQMGS | 166 | Q9UI15 | |
| GVVSQCMLQNNNNLE | 26 | Q8N5C8 | |
| ANVNGLMAIQLQNNQ | 386 | Q8TF66 | |
| ARAVLQNTAQINQML | 761 | P22670 | |
| VSNQSVRNRQEGLMI | 166 | P08567 | |
| RPVQNAMNQVGIVLN | 161 | Q7Z3K3 | |
| AMNQVGIVLNVQQGQ | 166 | Q7Z3K3 | |
| SQQGFLNAQMVAQRS | 1216 | Q9Y6Q9 | |
| LQRAINMQLNNGSAG | 171 | Q96LK8 | |
| QITAMANRTILVDNN | 531 | P46977 | |
| NNTVIGSQMQLQLGR | 261 | Q9C0A6 | |
| FQQNQTGNIMSRVTE | 276 | Q03518 | |
| QRANMSQVRQVGLLA | 21 | Q8IZU2 | |
| SAVQLHQMAVIGQQA | 471 | P11831 | |
| PEMNNQASRVAVVNQ | 896 | Q01082 | |
| QAQQLQGDALRQMQV | 6 | P42229 | |
| MINGNQAIREFIQGQ | 141 | Q5TBC7 | |
| KVNINVVNNMNRTAL | 91 | A6NHY2 | |
| DKQVVTQVRNQQMCG | 116 | P43234 | |
| MVALLLAQGANINAQ | 486 | Q8IWZ3 | |
| NIRASMQQQQQLASA | 36 | Q9Y3Y2 | |
| VQSAIRMNKNRINNA | 101 | Q9HBJ8 | |
| NGSMLQRALLLQQLQ | 81 | Q9ULV3 | |
| TQAPINAQMLAQRQR | 1226 | Q15596 | |
| NLNAAMNIARALQLS | 236 | Q9BXT8 | |
| RQFLGQMTQLNQLLG | 221 | P35443 | |
| MAELNAIIGQQQLQA | 116 | Q04724 | |
| VGQMQILRQQIANEL | 951 | Q12768 | |
| RVMGVDVQALNNQVG | 36 | Q8N443 | |
| LQSQVLQAMRQRGIA | 126 | Q9BU61 | |
| SGQQNNIGMVVIRGN | 51 | P62308 | |
| LNLNQGMDNGRSTLV | 226 | O95210 | |
| TMAELNAIIGQQLQA | 121 | Q04727 | |
| LRLQMNFINQAQLGI | 396 | Q9NR96 | |
| AAAQAMQTININGVQ | 431 | Q02086 | |
| QDLNGNNQSVTRQKM | 186 | P40763 | |
| LQNTMVNLGLQNACD | 96 | P11216 | |
| NEQQSVLQRIAAPNM | 1011 | Q14683 | |
| MLAVSQGRVQTNVLN | 2501 | Q9P273 | |
| QGDMRQALNNLQSTF | 226 | P35250 | |
| NQAQLAMNHLSGQRL | 406 | O95758 | |
| GFTALQMGNENVQQL | 466 | Q9H2K2 | |
| QMGNENVQQLLQEGI | 471 | Q9H2K2 | |
| MTELNAIIGQQQLQA | 116 | Q04726 | |
| LIGQVMNQLGQQLVS | 821 | Q9Y5L0 | |
| AMRSVLTQVLTNQQN | 261 | Q6ZT12 | |
| NVTDQAIAGLNGMQL | 311 | P26368 | |
| KMVAQAQQARQDAGI | 246 | Q8NEE8 | |
| NQQFIQQMVQALAGA | 556 | Q9UHD9 | |
| QQMVQALAGANAPQL | 561 | Q9UHD9 | |
| SANAVERIVPQNMQN | 111 | Q8TE54 | |
| NRNQDMSGQQAAQLA | 901 | Q6N021 | |
| QQLEQLNSMGFINRE | 561 | Q9NRR5 | |
| NALVQMADGNQAQLA | 376 | P26599 | |
| MVSQANRTVLENLGN | 361 | Q96RL6 | |
| AAQMAQVLQFNRDQG | 51 | P48595 | |
| ISAMVNSNNDRGVVQ | 221 | O95932 | |
| RQQQEQQLARMVSAL | 1306 | Q9UPQ9 | |
| QQLARMVSALQQQQQ | 1311 | Q9UPQ9 | |
| LIQQTMRQLNNHFGR | 2251 | O95071 | |
| GMNLNNISELIISNR | 171 | B1APH4 | |
| QQAGQQRISMQEIQT | 276 | Q96PN7 | |
| NGQQQQAMSFAILRI | 431 | P22459 | |
| LMQRQLQQSQAVRQT | 4226 | O14686 | |
| TMSLQQVINARNALA | 391 | Q9ULV0 |